Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:Experimental Neoplasms
go back to main search page
Accession:DOID:9002170 term browser browse the term
Definition:Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.
Synonyms:exact_synonym: Experimental Neoplasm
 primary_id: MESH:D009374
For additional species annotation, visit the Alliance of Genome Resources.



show annotations for term's descendants           Sort by:
 
Experimental Neoplasms term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABL1 ABL proto-oncogene 1, non-receptor tyrosine kinase EXP CTD Direct Evidence: marker/mechanism CTD PMID:19878872 NCBI chr 9:130,713,043...130,887,675
Ensembl chr 9:130,713,016...130,887,675
JBrowse link
G AHR aryl hydrocarbon receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:9496914 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
JBrowse link
G AOC4P amine oxidase copper containing 4, pseudogene EXP CTD Direct Evidence: therapeutic CTD PMID:32325081 NCBI chr17:42,867,145...42,869,217
Ensembl chr17:42,865,922...42,874,369
JBrowse link
G ARL6IP5 ADP ribosylation factor like GTPase 6 interacting protein 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:29545876 NCBI chr 3:69,084,937...69,106,092
Ensembl chr 3:69,084,937...69,106,092
JBrowse link
G ARNT aryl hydrocarbon receptor nuclear translocator EXP CTD Direct Evidence: marker/mechanism CTD PMID:9496914 NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708
JBrowse link
G AXL AXL receptor tyrosine kinase EXP CTD Direct Evidence: marker/mechanism CTD PMID:26206560 NCBI chr19:41,219,223...41,261,766
Ensembl chr19:41,219,223...41,261,766
JBrowse link
G BCR BCR activator of RhoGEF and GTPase EXP CTD Direct Evidence: marker/mechanism CTD PMID:19878872 NCBI chr22:23,180,509...23,318,037
Ensembl chr22:23,179,704...23,318,037
JBrowse link
G BRAF B-Raf proto-oncogene, serine/threonine kinase EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
JBrowse link
G BSG basigin (Ok blood group) EXP CTD Direct Evidence: marker/mechanism CTD PMID:21165561 NCBI chr19:571,283...583,493
Ensembl chr19:571,277...583,494
JBrowse link
G CCND1 cyclin D1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20932960 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
JBrowse link
G CDH1 cadherin 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27224422 NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
JBrowse link
G CDK4 cyclin dependent kinase 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20932960 NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
JBrowse link
G CTCF CCCTC-binding factor IMP human breast cancer cells in mouse model RGD PMID:21896759 RGD:151356745 NCBI chr16:67,562,526...67,639,185
Ensembl chr16:67,562,467...67,639,177
JBrowse link
G DDR1 discoidin domain receptor tyrosine kinase 1 treatment IMP human cancer cells in mouse model RGD PMID:26719540 RGD:11520844 NCBI chr 6:30,880,970...30,900,156
Ensembl chr 6:30,876,421...30,900,156
JBrowse link
G ENO2 enolase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22613180 NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:14612517 NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426
JBrowse link
G ERGIC3 ERGIC and golgi 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27588471 NCBI chr20:35,542,078...35,557,634
Ensembl chr20:35,542,038...35,557,634
JBrowse link
G ESRRA estrogen related receptor alpha EXP CTD Direct Evidence: marker/mechanism CTD PMID:34524571 NCBI chr11:64,305,524...64,316,743
Ensembl chr11:64,305,497...64,316,743
JBrowse link
G F2R coagulation factor II thrombin receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:17374729 NCBI chr 5:76,716,126...76,735,770
Ensembl chr 5:76,716,126...76,735,770
JBrowse link
G GREP1 glycine rich extracellular protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:34652879 NCBI chr16:2,988,262...3,002,011
Ensembl chr16:2,988,256...3,002,016
JBrowse link
G HDAC6 histone deacetylase 6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:34524571 NCBI chr  X:48,801,398...48,824,982
Ensembl chr  X:48,801,377...48,824,982
JBrowse link
G HGF hepatocyte growth factor EXP CTD Direct Evidence: therapeutic CTD PMID:21273587 NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha EXP CTD Direct Evidence: marker/mechanism CTD PMID:28574600 NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
JBrowse link
G HRAS HRas proto-oncogene, GTPase EXP CTD Direct Evidence: marker/mechanism CTD PMID:3433577 PMID:11552296 PMID:26558449 NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321
JBrowse link
G HRH2 histamine receptor H2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:6224980 NCBI chr 5:175,658,071...175,710,756
Ensembl chr 5:175,658,030...175,710,756
JBrowse link
G IFNB1 interferon beta 1 EXP CTD Direct Evidence: therapeutic CTD PMID:2297754 NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942
JBrowse link
G IFNG interferon gamma EXP CTD Direct Evidence: therapeutic CTD PMID:15711825 NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
JBrowse link
G IL12A interleukin 12A EXP CTD Direct Evidence: therapeutic CTD PMID:17332360 NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
JBrowse link
G IL12B interleukin 12B EXP CTD Direct Evidence: therapeutic CTD PMID:17332360 NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
JBrowse link
G IL2 interleukin 2 EXP CTD Direct Evidence: therapeutic CTD PMID:1949363 PMID:3495671 PMID:22306178 NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
JBrowse link
G ITGAV integrin subunit alpha V treatment IMP human cells in rat model RGD PMID:20841470 RGD:152998949 NCBI chr 2:186,590,056...186,680,901
Ensembl chr 2:186,590,010...186,680,901
JBrowse link
G KIF11 kinesin family member 11 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17974955 NCBI chr10:92,593,130...92,655,395
Ensembl chr10:92,574,105...92,655,395
JBrowse link
G KRAS KRAS proto-oncogene, GTPase EXP CTD Direct Evidence: marker/mechanism CTD PMID:9205081 PMID:10813127 PMID:21311774 PMID:25851810 PMID:26390243 NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936
JBrowse link
G LDHA lactate dehydrogenase A ISO RGD PMID:11085542 RGD:1600281 NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425
JBrowse link
G LECT2 leukocyte cell derived chemotaxin 2 EXP CTD Direct Evidence: therapeutic CTD PMID:30453282 NCBI chr 5:135,946,904...135,954,983
Ensembl chr 5:135,922,279...135,954,983
JBrowse link
G LINC01089 long intergenic non-protein coding RNA 1089 EXP CTD Direct Evidence: marker/mechanism CTD PMID:34561789 NCBI chr12:121,795,267...121,802,946
Ensembl chr12:121,795,267...121,803,906
JBrowse link
G MAPK7 mitogen-activated protein kinase 7 EXP CTD Direct Evidence: marker/mechanism CTD PMID:29507229 NCBI chr17:19,377,750...19,383,544
Ensembl chr17:19,377,721...19,383,544
JBrowse link
G MIR1193 microRNA 1193 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:101,030,052...101,030,129
Ensembl chr14:101,030,052...101,030,129
JBrowse link
G MIR143 microRNA 143 EXP CTD Direct Evidence: therapeutic CTD PMID:28736328 PMID:31152816 NCBI chr 5:149,428,918...149,429,023
Ensembl chr 5:149,428,918...149,429,023
JBrowse link
G MIR300 microRNA 300 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:101,041,363...101,041,445
Ensembl chr14:101,041,363...101,041,445
JBrowse link
G MIR323A microRNA 323a ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:101,025,732...101,025,817
Ensembl chr14:101,025,732...101,025,817
JBrowse link
G MIR337 microRNA 337 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:100,874,493...100,874,585
Ensembl chr14:100,874,493...100,874,585
JBrowse link
G MIR34B microRNA 34b EXP CTD Direct Evidence: therapeutic CTD PMID:22113133 NCBI chr11:111,512,938...111,513,021
Ensembl chr11:111,512,938...111,513,021
JBrowse link
G MIR369 microRNA 369 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:101,065,598...101,065,667
Ensembl chr14:101,065,598...101,065,667
JBrowse link
G MIR370 microRNA 370 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:100,911,139...100,911,213
Ensembl chr14:100,911,139...100,911,213
JBrowse link
G MIR376A1 microRNA 376a-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:101,040,782...101,040,849
Ensembl chr14:101,040,782...101,040,849
JBrowse link
G MIR376B microRNA 376b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:101,040,436...101,040,535
Ensembl chr14:101,040,436...101,040,535
JBrowse link
G MIR379 microRNA 379 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:101,022,066...101,022,132
Ensembl chr14:101,022,066...101,022,132
JBrowse link
G MIR381 microRNA 381 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:101,045,920...101,045,994
Ensembl chr14:101,045,920...101,045,994
JBrowse link
G MIR382 microRNA 382 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:101,054,306...101,054,381
Ensembl chr14:101,054,306...101,054,381
JBrowse link
G MIR431 microRNA 431 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:100,881,007...100,881,120
Ensembl chr14:100,881,007...100,881,120
JBrowse link
G MIR433 microRNA 433 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:100,881,886...100,881,978
Ensembl chr14:100,881,886...100,881,978
JBrowse link
G MIR485 microRNA 485 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:101,055,419...101,055,491
Ensembl chr14:101,055,419...101,055,491
JBrowse link
G MIR487B microRNA 487b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:101,046,455...101,046,538
Ensembl chr14:101,046,455...101,046,538
JBrowse link
G MIR495 microRNA 495 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:101,033,755...101,033,836
Ensembl chr14:101,033,755...101,033,836
JBrowse link
G MIR506 microRNA 506 EXP CTD Direct Evidence: therapeutic CTD PMID:21726609 NCBI chr  X:147,230,720...147,230,843
Ensembl chr  X:147,230,720...147,230,843
JBrowse link
G MIR654 microRNA 654 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:101,040,219...101,040,299
Ensembl chr14:101,040,219...101,040,299
JBrowse link
G MIR758 microRNA 758 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:101,026,020...101,026,107
Ensembl chr14:101,026,020...101,026,107
JBrowse link
G MIR770 microRNA 770 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28030816 NCBI chr14:100,852,390...100,852,487
Ensembl chr14:100,852,390...100,852,487
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 EXP CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:9496914 PMID:21034357 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
JBrowse link
G NRAS NRAS proto-oncogene, GTPase EXP CTD Direct Evidence: marker/mechanism CTD PMID:9205081 NCBI chr 1:114,704,469...114,716,771
Ensembl chr 1:114,704,469...114,716,771
JBrowse link
G PARG poly(ADP-ribose) glycohydrolase EXP CTD Direct Evidence: therapeutic CTD PMID:33044785 NCBI chr10:49,818,279...49,942,027
Ensembl chr10:49,818,279...49,970,203
JBrowse link
G PCNA proliferating cell nuclear antigen EXP CTD Direct Evidence: marker/mechanism CTD PMID:20932960 NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
JBrowse link
G POLR1H RNA polymerase I subunit H EXP CTD Direct Evidence: marker/mechanism CTD PMID:16609701 NCBI chr 6:30,060,062...30,064,907
Ensembl chr 6:30,058,899...30,064,909
JBrowse link
G PRL prolactin treatment ISO RGD PMID:26983879 RGD:152177690 NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
JBrowse link
G PRNP prion protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:21265952 NCBI chr20:4,686,456...4,701,588
Ensembl chr20:4,686,350...4,701,590
JBrowse link
G PUF60 poly(U) binding splicing factor 60 EXP CTD Direct Evidence: therapeutic CTD PMID:21435101 NCBI chr 8:143,816,344...143,829,315
Ensembl chr 8:143,816,344...143,829,352
JBrowse link
G RASAL2 RAS protein activator like 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:34826200 NCBI chr 1:178,094,104...178,478,850
Ensembl chr 1:178,094,104...178,484,147
JBrowse link
G RB1 RB transcriptional corepressor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27137931 NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit EXP CTD Direct Evidence: marker/mechanism CTD PMID:20932960 NCBI chr11:65,653,601...65,662,916
Ensembl chr11:65,653,599...65,663,090
JBrowse link
G RICTOR RPTOR independent companion of MTOR complex 2 disease_progression ISO RGD PMID:24244675 RGD:152995458 NCBI chr 5:38,937,920...39,074,399
Ensembl chr 5:38,937,920...39,074,399
JBrowse link
G SPARC secreted protein acidic and cysteine rich EXP CTD Direct Evidence: therapeutic CTD PMID:20164124 NCBI chr 5:151,661,096...151,686,915
Ensembl chr 5:151,661,096...151,686,975
JBrowse link
G SPP1 secreted phosphoprotein 1 EXP CTD Direct Evidence: therapeutic CTD PMID:21852811 NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
JBrowse link
G STAT3 signal transducer and activator of transcription 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:29507229 NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,540
JBrowse link
G STIM1 stromal interaction molecule 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27863410 NCBI chr11:3,854,604...4,093,210
Ensembl chr11:3,854,527...4,093,210
JBrowse link
G TNF tumor necrosis factor EXP CTD Direct Evidence: therapeutic CTD PMID:1674182 PMID:3361654 PMID:12627504 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TNFSF10 TNF superfamily member 10 EXP CTD Direct Evidence: therapeutic CTD PMID:17767197 PMID:24345465 NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
JBrowse link
G TOB1 transducer of ERBB2, 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12756225 NCBI chr17:50,862,223...50,867,978
Ensembl chr17:50,862,223...50,867,978
JBrowse link
G TP53 tumor protein p53 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12756225 PMID:27137931 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
G TP63 tumor protein p63 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25739959 NCBI chr 3:189,596,746...189,897,276
Ensembl chr 3:189,631,389...189,897,276
JBrowse link
G TRIM47 tripartite motif containing 47 EXP CTD Direct Evidence: marker/mechanism CTD PMID:31981573 NCBI chr17:75,874,164...75,878,581
Ensembl chr17:75,874,164...75,878,581
JBrowse link
G TXN thioredoxin EXP CTD Direct Evidence: marker/mechanism CTD PMID:28574600 NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
JBrowse link
G URI1 URI1 prefoldin like chaperone EXP CTD Direct Evidence: marker/mechanism CTD PMID:21397856 NCBI chr19:29,923,657...30,016,612
Ensembl chr19:29,923,644...30,016,612
JBrowse link
G VEGFA vascular endothelial growth factor A EXP CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:20376344 PMID:20932960 PMID:28574600 NCBI chr 6:43,770,209...43,786,487
Ensembl chr 6:43,770,184...43,786,487
JBrowse link
Avian Sarcoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G RHOB ras homolog family member B ISO RGD PMID:1710770 RGD:704375 NCBI chr 2:20,447,074...20,449,440
Ensembl chr 2:20,447,074...20,449,440
JBrowse link
Carcinoma, Lewis Lung term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G C3 complement C3 treatment ISO RGD PMID:16947020 RGD:7401280 NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
JBrowse link
G COQ7 coenzyme Q7, hydroxylase susceptibility ISO RGD PMID:23166727 RGD:10402105 NCBI chr16:19,067,614...19,083,097
Ensembl chr16:19,067,614...19,080,095
JBrowse link
G CSF1R colony stimulating factor 1 receptor ameliorates ISO mouse cell line in a mouse model RGD PMID:20008303 RGD:150524291 NCBI chr 5:150,053,295...150,113,365
Ensembl chr 5:150,053,291...150,113,372
JBrowse link
G IL18 interleukin 18 treatment ISO RGD PMID:16767432 RGD:8655941 NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
JBrowse link
G IL2 interleukin 2 treatment ISO RGD PMID:9399664 RGD:8663451 NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
JBrowse link
G IRAK3 interleukin 1 receptor associated kinase 3 IMP RGD PMID:21278795 RGD:36049796 NCBI chr12:66,189,214...66,254,622
Ensembl chr12:66,189,195...66,254,622
JBrowse link
G JAM3 junctional adhesion molecule 3 ISO RGD PMID:15994945 RGD:7488936 NCBI chr11:134,069,072...134,152,001
Ensembl chr11:134,069,071...134,152,001
JBrowse link
G LECT2 leukocyte cell derived chemotaxin 2 EXP CTD Direct Evidence: therapeutic CTD PMID:30453282 NCBI chr 5:135,946,904...135,954,983
Ensembl chr 5:135,922,279...135,954,983
JBrowse link
G MAPK14 mitogen-activated protein kinase 14 ameliorates ISO mouse cell line in a mouse model RGD PMID:29907597 RGD:151665504 NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,677...36,111,236
JBrowse link
G MYD88 MYD88 innate immune signal transduction adaptor treatment ISO mouse cell line in a mouse model RGD PMID:26111447 RGD:150521531 NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,478...38,143,024
JBrowse link
G TXNRD1 thioredoxin reductase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16565519 NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
JBrowse link
Ehrlich tumor carcinoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CD40 CD40 molecule treatment ISO RGD PMID:19269163 RGD:11352683 NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
JBrowse link
G CD40LG CD40 ligand treatment ISO RGD PMID:19269163 RGD:11352683 NCBI chr  X:136,648,158...136,660,390
Ensembl chr  X:136,648,158...136,660,390
JBrowse link
G CEACAM20 CEA cell adhesion molecule 20 EXP CTD Direct Evidence: marker/mechanism CTD PMID:34605108 NCBI chr19:44,506,159...44,529,675
Ensembl chr19:44,501,677...44,529,788
JBrowse link
Experimental Leukemia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CBL Cbl proto-oncogene treatment ISO RGD PMID:20890046 RGD:11038805 NCBI chr11:119,206,339...119,308,149
Ensembl chr11:119,206,298...119,313,926
JBrowse link
G CBX7 chromobox 7 ISO RGD PMID:25434821 RGD:11352713 NCBI chr22:39,130,772...39,152,680
Ensembl chr22:39,120,167...39,152,680
JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A ISO RGD PMID:10090949 RGD:11251764 NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
JBrowse link
G FGFR1 fibroblast growth factor receptor 1 treatment IMP RGD PMID:22781593 RGD:11352669 NCBI chr 8:38,411,143...38,468,635
Ensembl chr 8:38,400,215...38,468,834
JBrowse link
G IL1A interleukin 1 alpha treatment ISO RGD PMID:2117483 RGD:11051972 NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
JBrowse link
G LAT2 linker for activation of T cells family member 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:32587277 NCBI chr 7:74,210,006...74,229,834
Ensembl chr 7:74,199,652...74,229,834
JBrowse link
G NRAS NRAS proto-oncogene, GTPase induced ISO DNA:transversion mutation, loss of heterozygosity:cds: RGD PMID:9142215 RGD:11535063 NCBI chr 1:114,704,469...114,716,771
Ensembl chr 1:114,704,469...114,716,771
JBrowse link
G PTPN11 protein tyrosine phosphatase non-receptor type 11 EXP CTD Direct Evidence: marker/mechanism CTD PMID:32417439 NCBI chr12:112,418,947...112,509,918
Ensembl chr12:112,418,351...112,509,918
JBrowse link
G RUNX1 RUNX family transcription factor 1 treatment ISO RGD PMID:19236814 RGD:11251683 NCBI chr21:35,372,507...35,580,764
Ensembl chr21:34,787,801...36,004,667
JBrowse link
G RUNX1 RUNX family transcription factor 1 treatment ISO RGD PMID:19236814 RGD:11251683 NCBI chr21:34,787,801...35,049,302
Ensembl chr21:34,787,801...36,004,667
JBrowse link
Experimental Liver Neoplasms term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB11 ATP binding cassette subfamily B member 11 ISO RGD PMID:15853769 RGD:1598580 NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
JBrowse link
G ADSL adenylosuccinate lyase ISO protein:increased activity:liver (rat) RGD PMID:2937404 RGD:1598766 NCBI chr22:40,346,500...40,387,527
Ensembl chr22:40,346,461...40,390,463
JBrowse link
G AFP alpha fetoprotein EXP CTD Direct Evidence: marker/mechanism CTD PMID:24012840 PMID:32961231 NCBI chr 4:73,436,221...73,456,174
Ensembl chr 4:73,431,138...73,456,174
JBrowse link
G AGPS alkylglycerone phosphate synthase ISO RGD PMID:7407223 RGD:1598794 NCBI chr 2:177,392,773...177,543,834
Ensembl chr 2:177,392,746...177,567,024
JBrowse link
G ALAS2 5'-aminolevulinate synthase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr  X:55,009,055...55,030,977
Ensembl chr  X:55,009,055...55,030,977
JBrowse link
G APOA4 apolipoprotein A4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
JBrowse link
G APOC2 apolipoprotein C2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr19:44,946,051...44,949,565
Ensembl chr19:44,946,035...44,949,565
JBrowse link
G ARID1A AT-rich interaction domain 1A disease_progression ISO RGD PMID:26569409 RGD:11344640 NCBI chr 1:26,696,015...26,782,104
Ensembl chr 1:26,693,236...26,782,104
JBrowse link
G ARRB2 arrestin beta 2 ISO mRNA, protein:increased expression:liver (rat) RGD PMID:21167192 RGD:5509890 NCBI chr17:4,710,632...4,721,497
Ensembl chr17:4,710,596...4,721,499
JBrowse link
G ATP7A ATPase copper transporting alpha EXP CTD Direct Evidence: marker/mechanism CTD PMID:23792645 NCBI chr  X:77,910,693...78,050,395
Ensembl chr  X:77,910,690...78,050,395
JBrowse link
G ATP7B ATPase copper transporting beta EXP CTD Direct Evidence: marker/mechanism CTD PMID:23792645 NCBI chr13:51,932,669...52,012,132
Ensembl chr13:51,930,436...52,012,125
JBrowse link
G BAK1 BCL2 antagonist/killer 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
JBrowse link
G BBC3 BCL2 binding component 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr19:47,220,824...47,232,860
Ensembl chr19:47,220,822...47,232,766
JBrowse link
G BCL2 BCL2 apoptosis regulator EXP CTD Direct Evidence: marker/mechanism CTD PMID:10426811 PMID:28100771 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G BCL2L1 BCL2 like 1 ISO
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:10426811 PMID:28100771 PMID:22414765 RGD:11353865 NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 ISO mRNA, protein:increased expression:liver RGD PMID:18246794 RGD:2293125 NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
JBrowse link
G CA3 carbonic anhydrase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 8:85,438,859...85,449,040
Ensembl chr 8:85,373,436...85,449,040
JBrowse link
G CAD carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase ISO protein:increased activity:liver (rat) RGD PMID:13618893 RGD:5132586 NCBI chr 2:27,217,369...27,243,943
Ensembl chr 2:27,217,369...27,243,943
JBrowse link
G CCL20 C-C motif chemokine ligand 20 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30603057 NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
JBrowse link
G CCNB1 cyclin B1 ISO mRNA:increased expression:liver RGD PMID:17342310 RGD:2315991 NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
JBrowse link
G CCND1 cyclin D1 ISO
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:28100771 PMID:17055752 RGD:2289139 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
JBrowse link
G CCNDBP1 cyclin D1 binding protein 1 EXP CTD Direct Evidence: therapeutic CTD PMID:16501603 NCBI chr15:43,185,403...43,197,177
Ensembl chr15:43,185,118...43,197,177
JBrowse link
G CCNG1 cyclin G1 ISO RGD PMID:27982046 RGD:151361200 NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,446,151
JBrowse link
G CCNG2 cyclin G2 ISO RGD PMID:27982046 RGD:151361200 NCBI chr 4:77,157,207...77,170,060
Ensembl chr 4:77,157,207...77,433,388
JBrowse link
G CD40LG CD40 ligand ISO RGD PMID:19035311 RGD:5491179 NCBI chr  X:136,648,158...136,660,390
Ensembl chr  X:136,648,158...136,660,390
JBrowse link
G CD63 CD63 molecule EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr12:55,725,323...55,729,673
Ensembl chr12:55,725,323...55,729,707
JBrowse link
G CDH1 cadherin 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20118494 PMID:25319454 NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A ISO protein:decreased expression:liver: RGD PMID:8640740 RGD:8662309 NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B disease_progression ISO mRNA:increased expression:liver (rat) RGD PMID:19533683 RGD:2315050 NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
JBrowse link
G CDKN1C cyclin dependent kinase inhibitor 1C disease_progression ISO protein:decreased expression:liver (rat)
protein:increased expression:liver (rat)
mRNA:increased expression:liver (rat)
RGD PMID:26606000 PMID:3965145 PMID:19533683 RGD:11354707, RGD:152998958, RGD:2315050 NCBI chr11:2,883,218...2,885,775
Ensembl chr11:2,883,213...2,885,775
JBrowse link
G COPS5 COP9 signalosome subunit 5 ISO protein:increased expression:liver (rat) RGD PMID:26606000 RGD:11354707 NCBI chr 8:67,043,079...67,062,133
Ensembl chr 8:67,043,079...67,083,783
JBrowse link
G CP ceruloplasmin EXP CTD Direct Evidence: marker/mechanism CTD PMID:23792645 NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
JBrowse link
G CPS1 carbamoyl-phosphate synthase 1 severity ISO mRNA:decreased expression:liver RGD PMID:3387993 RGD:2303406 NCBI chr 2:210,477,685...210,679,107
Ensembl chr 2:210,477,682...210,679,107
JBrowse link
G CTNNB1 catenin beta 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11280770 PMID:20118494 PMID:21147764 NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
JBrowse link
G CXCL9 C-X-C motif chemokine ligand 9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 ISO mRNA:increased expression:liver RGD PMID:22687991 RGD:7296954 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11376689 PMID:21147764 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
JBrowse link
G CYP2A7 cytochrome P450 family 2 subfamily A member 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr19:40,875,439...40,882,231
Ensembl chr19:40,875,439...40,882,752
JBrowse link
G CYP2C8 cytochrome P450 family 2 subfamily C member 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr10:95,036,772...95,069,497
Ensembl chr10:95,036,772...95,069,497
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18056438 NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
JBrowse link
G CYP2F1 cytochrome P450 family 2 subfamily F member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr19:41,114,432...41,128,381
Ensembl chr19:41,114,432...41,128,381
JBrowse link
G DHODH dihydroorotate dehydrogenase (quinone) ISO protein:increased activity:liver (rat) RGD PMID:6331524 RGD:5132618 NCBI chr16:72,008,744...72,027,659
Ensembl chr16:72,008,588...72,027,664
JBrowse link
G DTYMK deoxythymidylate kinase ISO protein:increased activity:tumor (rat) RGD PMID:6244089 RGD:5133686 NCBI chr 2:241,675,747...241,686,815
Ensembl chr 2:241,675,747...241,686,944
JBrowse link
G ENO2 enolase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:2910524 NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
JBrowse link
G EPHX1 epoxide hydrolase 1 ISO RGD PMID:7260898 RGD:11252158 NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
JBrowse link
G F12 coagulation factor XII EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 5:177,402,141...177,409,564
Ensembl chr 5:177,402,133...177,416,583
JBrowse link
G FAS Fas cell surface death receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:30737368 NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
JBrowse link
G FOXM1 forkhead box M1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:15082532 NCBI chr12:2,857,680...2,877,174
Ensembl chr12:2,857,680...2,877,174
JBrowse link
G FOXP4-AS1 FOXP4 antisense RNA 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:34545456 NCBI chr 6:41,523,895...41,548,621
Ensembl chr 6:41,452,889...41,548,621
JBrowse link
G GJB1 gap junction protein beta 1 ISO
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:18308698 PMID:1336494 RGD:7349398 NCBI chr  X:71,215,239...71,225,516
Ensembl chr  X:71,212,811...71,225,516
JBrowse link
G GJB2 gap junction protein beta 2 ISO RGD PMID:1336494 RGD:7349398 NCBI chr13:20,187,470...20,192,938
Ensembl chr13:20,187,463...20,192,938
JBrowse link
G GLUL glutamate-ammonia ligase EXP CTD Direct Evidence: marker/mechanism CTD PMID:20118494 PMID:21147764 NCBI chr 1:182,378,098...182,391,790
Ensembl chr 1:182,378,098...182,392,206
JBrowse link
G GRP gastrin releasing peptide EXP CTD Direct Evidence: marker/mechanism CTD PMID:2910524 NCBI chr18:59,219,189...59,230,771
Ensembl chr18:59,220,158...59,230,774
JBrowse link
G GSTP1 glutathione S-transferase pi 1 ISO
EXP
protein:increased expression:liver (rat)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:2563599 PMID:3124819 PMID:7585603 PMID:20188851 PMID:12016164 More... RGD:2317823, RGD:152998958 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
JBrowse link
G H19 H19 imprinted maternally expressed transcript ISO
EXP
DNA:hypomethylation:promoter
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:11420682 PMID:15352122 RGD:1342455 NCBI chr11:1,995,176...2,001,466
Ensembl chr11:1,995,166...2,001,470
JBrowse link
G HAT1 histone acetyltransferase 1 ISO protein:increased expression:liver RGD PMID:17182829 RGD:2316578 NCBI chr 2:171,922,461...171,983,686
Ensembl chr 2:171,922,448...171,983,686
JBrowse link
G HGF hepatocyte growth factor EXP CTD Direct Evidence: marker/mechanism CTD PMID:11896611 NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
JBrowse link
G HRAS HRas proto-oncogene, GTPase EXP CTD Direct Evidence: marker/mechanism CTD PMID:7955063 PMID:20118494 PMID:21147764 PMID:27517622 NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321
JBrowse link
G HTR2C 5-hydroxytryptamine receptor 2C ISO protein:increased expression:brainstem, cerebral cortex RGD PMID:17258772 RGD:1624998 NCBI chr  X:114,584,086...114,910,061
Ensembl chr  X:114,584,078...114,910,061
JBrowse link
G IGF2 insulin like growth factor 2 treatment ISO RGD PMID:22425635 RGD:10402567 NCBI chr11:2,129,117...2,149,566
Ensembl chr11:2,129,112...2,158,391
JBrowse link
G IGF2R insulin like growth factor 2 receptor ISO RGD PMID:15057872 PMID:9652747 RGD:2311623, RGD:2311630 NCBI chr 6:159,969,082...160,111,504
Ensembl chr 6:159,969,082...160,113,507
JBrowse link
G IKBKG inhibitor of nuclear factor kappa B kinase regulatory subunit gamma EXP CTD Direct Evidence: marker/mechanism CTD PMID:30737368 NCBI chr  X:154,541,238...154,565,046
Ensembl chr  X:154,541,199...154,565,046
JBrowse link
G IL6 interleukin 6 disease_progression EXP
ISO
CTD Direct Evidence: marker/mechanism
protein:increased expression:blood serum (mouse)
CTD
RGD
PMID:26297436 PMID:26569409 RGD:11344640 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G INSR insulin receptor disease_progression ISO associated with Diabetes Mellitus, Experimental;protein:increased expression:cytoplasm,liver (rat) RGD PMID:15520221 RGD:2306052 NCBI chr19:7,112,265...7,294,414
Ensembl chr19:7,112,255...7,294,414
JBrowse link
G JAK2 Janus kinase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
JBrowse link
G KAT6A lysine acetyltransferase 6A ISO protein:increased expression:liver (rat) RGD PMID:17083329 RGD:2312274 NCBI chr 8:41,929,479...42,051,987
Ensembl chr 8:41,929,479...42,051,994
JBrowse link
G KDR kinase insert domain receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:11956651 NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
JBrowse link
G KRAS KRAS proto-oncogene, GTPase disease_progression EXP
ISO
CTD Direct Evidence: marker/mechanism
mRNA:increased expression:liver (rat)
CTD
RGD
PMID:8603461 PMID:19533683 RGD:2315050 NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936
JBrowse link
G MAP2K1 mitogen-activated protein kinase kinase 1 ISO associated with Diabetes Mellitus, Experimental;protein:increased expression:liver RGD PMID:15520221 RGD:2306052 NCBI chr15:66,386,912...66,491,544
Ensembl chr15:66,386,837...66,491,656
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
JBrowse link
G MET MET proto-oncogene, receptor tyrosine kinase EXP CTD Direct Evidence: marker/mechanism CTD PMID:11956651 NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
JBrowse link
G MFGE8 milk fat globule EGF and factor V/VIII domain containing EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr15:88,898,683...88,913,379
Ensembl chr15:88,898,683...88,913,468
JBrowse link
G MIR10A microRNA 10a EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr17:48,579,838...48,579,947
Ensembl chr17:48,579,838...48,579,947
JBrowse link
G MIR125A microRNA 125a EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr19:51,693,254...51,693,339
Ensembl chr19:51,693,254...51,693,339
JBrowse link
G MIR145 microRNA 145 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 5:149,430,646...149,430,733
Ensembl chr 5:149,430,646...149,430,733
JBrowse link
G MIR151A microRNA 151a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 8:140,732,564...140,732,653
Ensembl chr 8:140,732,564...140,732,653
JBrowse link
G MIR181C microRNA 181c EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr19:13,874,699...13,874,808
Ensembl chr19:13,874,699...13,874,808
JBrowse link
G MIR181D microRNA 181d EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr19:13,874,875...13,875,011
Ensembl chr19:13,874,875...13,875,011
JBrowse link
G MIR183 microRNA 183 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 7:129,774,905...129,775,014
Ensembl chr 7:129,774,905...129,775,014
JBrowse link
G MIR186 microRNA 186 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:71,067,631...71,067,716
Ensembl chr 1:71,067,631...71,067,716
JBrowse link
G MIR18A microRNA 18a EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr13:91,350,751...91,350,821
Ensembl chr13:91,350,751...91,350,821
JBrowse link
G MIR195 microRNA 195 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr17:7,017,615...7,017,701
Ensembl chr17:7,017,615...7,017,701
JBrowse link
G MIR196B microRNA 196b EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 7:27,169,480...27,169,563
Ensembl chr 7:27,169,480...27,169,563
JBrowse link
G MIR200B microRNA 200b EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:1,167,104...1,167,198
Ensembl chr 1:1,167,104...1,167,198
JBrowse link
G MIR206 microRNA 206 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 6:52,144,349...52,144,434
Ensembl chr 6:52,144,349...52,144,434
JBrowse link
G MIR212 microRNA 212 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr17:2,050,271...2,050,380
Ensembl chr17:2,050,271...2,050,380
JBrowse link
G MIR221 microRNA 221 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr  X:45,746,157...45,746,266
Ensembl chr  X:45,746,157...45,746,266
JBrowse link
G MIR26A1 microRNA 26a-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 3:37,969,404...37,969,480
Ensembl chr 3:37,969,404...37,969,480
JBrowse link
G MIR26B microRNA 26b EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 2:218,402,646...218,402,722
Ensembl chr 2:218,402,646...218,402,722
JBrowse link
G MIR300 microRNA 300 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr14:101,041,363...101,041,445
Ensembl chr14:101,041,363...101,041,445
JBrowse link
G MIR301A microRNA 301a EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr17:59,151,136...59,151,221
Ensembl chr17:59,151,136...59,151,221
JBrowse link
G MIR30A microRNA 30a EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 6:71,403,551...71,403,621
Ensembl chr 6:71,403,551...71,403,621
JBrowse link
G MIR30B microRNA 30b EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 8:134,800,520...134,800,607
Ensembl chr 8:134,800,520...134,800,607
JBrowse link
G MIR30D microRNA 30d EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 8:134,804,876...134,804,945
Ensembl chr 8:134,804,876...134,804,945
JBrowse link
G MIR30E microRNA 30e EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:40,754,355...40,754,446
Ensembl chr 1:40,754,355...40,754,446
JBrowse link
G MIR324 microRNA 324 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr17:7,223,297...7,223,379
Ensembl chr17:7,223,297...7,223,379
JBrowse link
G MIR331 microRNA 331 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr12:95,308,420...95,308,513
Ensembl chr12:95,308,420...95,308,513
JBrowse link
G MIR335 microRNA 335 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 7:130,496,111...130,496,204
Ensembl chr 7:130,496,111...130,496,204
JBrowse link
G MIR338 microRNA 338 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr17:81,125,883...81,125,949
Ensembl chr17:81,125,883...81,125,949
JBrowse link
G MIR339 microRNA 339 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 7:1,022,933...1,023,026
Ensembl chr 7:1,022,933...1,023,026
JBrowse link
G MIR340 microRNA 340 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 5:180,015,303...180,015,397
Ensembl chr 5:180,015,303...180,015,397
JBrowse link
G MIR34A microRNA 34a EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:9,151,668...9,151,777
Ensembl chr 1:9,151,668...9,151,777
JBrowse link
G MIR371A microRNA 371a ISO CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr19:53,787,675...53,787,741
Ensembl chr19:53,787,675...53,787,741
JBrowse link
G MIR383 microRNA 383 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 8:14,853,438...14,853,510
Ensembl chr 8:14,853,438...14,853,510
JBrowse link
G MIR409 microRNA 409 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr14:101,065,300...101,065,378
Ensembl chr14:101,065,300...101,065,378
JBrowse link
G MIR429 microRNA 429 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:1,169,005...1,169,087
Ensembl chr 1:1,169,005...1,169,087
JBrowse link
G MIR483 microRNA 483 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr11:2,134,134...2,134,209
Ensembl chr11:2,134,134...2,134,209
JBrowse link
G MIR505 microRNA 505 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr  X:139,924,148...139,924,231
Ensembl chr  X:139,924,148...139,924,231
JBrowse link
G MIR539 microRNA 539 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr14:101,047,321...101,047,398
Ensembl chr14:101,047,321...101,047,398
JBrowse link
G MIR598 microRNA 598 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 8:11,035,206...11,035,302
Ensembl chr 8:11,035,206...11,035,302
JBrowse link
G MIR652 microRNA 652 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr  X:110,055,329...110,055,426
Ensembl chr  X:110,055,329...110,055,426
JBrowse link
G MIR671 microRNA 671 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 7:151,238,421...151,238,538
Ensembl chr 7:151,238,421...151,238,538
JBrowse link
G MIR708 microRNA 708 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr11:79,402,022...79,402,109
Ensembl chr11:79,402,022...79,402,109
JBrowse link
G MIR760 microRNA 760 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:93,846,832...93,846,911
Ensembl chr 1:93,846,832...93,846,911
JBrowse link
G MIR92B microRNA 92b EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 1:155,195,177...155,195,272
Ensembl chr 1:155,195,177...155,195,272
JBrowse link
G MIR98 microRNA 98 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr  X:53,556,223...53,556,341
Ensembl chr  X:53,556,223...53,556,341
JBrowse link
G MIR99B microRNA 99b EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr19:51,692,612...51,692,681
Ensembl chr19:51,692,612...51,692,681
JBrowse link
G MIRLET7B microRNA let-7b EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr22:46,113,686...46,113,768
Ensembl chr22:46,113,686...46,113,768
JBrowse link
G MIRLET7D microRNA let-7d EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr 9:94,178,834...94,178,920
Ensembl chr 9:94,178,834...94,178,920
JBrowse link
G MIRLET7E microRNA let-7e EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr19:51,692,786...51,692,864
Ensembl chr19:51,692,786...51,692,864
JBrowse link
G MIRLET7I microRNA let-7i EXP CTD Direct Evidence: marker/mechanism CTD PMID:21035526 NCBI chr12:62,603,686...62,603,769
Ensembl chr12:62,603,686...62,603,769
JBrowse link
G MMP2 matrix metallopeptidase 2 ISO
EXP
CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression, increased activity:liver
CTD
RGD
PMID:30603057 PMID:19528495 PMID:19539802 RGD:2325736, RGD:2325734 NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
JBrowse link
G MMP9 matrix metallopeptidase 9 ISO mRNA, protein:increased expression, increased activity:liver RGD PMID:19528495 PMID:19539802 RGD:2325736, RGD:2325734 NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
JBrowse link
G MPEG1 macrophage expressed 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr11:59,208,510...59,212,927
Ensembl chr11:59,208,510...59,212,927
JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor ISO
EXP
mRNA:increased expression:liver (rat)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:9079223 PMID:11280770 PMID:18560566 PMID:3335218 RGD:10059623 NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
JBrowse link
G NOS2 nitric oxide synthase 2 ISO protein:increased expression:liver RGD PMID:10383909 RGD:2325277 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
JBrowse link
G NOTCH1 notch receptor 1 ISO protein:increased expression:liver RGD PMID:18942116 RGD:2325310 NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 ISO mRNA, protein:increased expression:liver (rat) RGD PMID:27867096 RGD:13442478 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
JBrowse link
G NR1H4 nuclear receptor subfamily 1 group H member 4 susceptibility ISO RGD PMID:17283114 RGD:14701032 NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
JBrowse link
G NR1I3 nuclear receptor subfamily 1 group I member 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17172636 PMID:24769335 PMID:25656644 NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
JBrowse link
G NRAS NRAS proto-oncogene, GTPase IMP human gene in mouse model RGD PMID:16286660 RGD:14975105 NCBI chr 1:114,704,469...114,716,771
Ensembl chr 1:114,704,469...114,716,771
JBrowse link
G PEMT phosphatidylethanolamine N-methyltransferase ISO protein:decreased expression:liver RGD PMID:7929120 RGD:1642378 NCBI chr17:17,505,563...17,592,142
Ensembl chr17:17,505,563...17,591,708
JBrowse link
G PLCL1 phospholipase C like 1 (inactive) disease_progression ISO mRNA:increased expression:liver (rat) RGD PMID:19533683 RGD:2315050 NCBI chr 2:197,804,593...198,149,863
Ensembl chr 2:197,804,593...198,572,581
JBrowse link
G PML PML nuclear body scaffold EXP CTD Direct Evidence: therapeutic CTD PMID:20377131 NCBI chr15:73,994,716...74,047,827
Ensembl chr15:73,994,673...74,047,827
JBrowse link
G PPAT phosphoribosyl pyrophosphate amidotransferase EXP CTD Direct Evidence: marker/mechanism CTD PMID:761203 NCBI chr 4:56,393,362...56,435,615
Ensembl chr 4:56,393,362...56,435,615
JBrowse link
G PPP2CA protein phosphatase 2 catalytic subunit alpha ISO mRNA:increased expression:liver (rat) RGD PMID:2562181 RGD:8693574 NCBI chr 5:134,194,332...134,226,073
Ensembl chr 5:134,194,035...134,226,073
JBrowse link
G PRDX1 peroxiredoxin 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27517622 NCBI chr 1:45,511,051...45,522,890
Ensembl chr 1:45,510,914...45,542,732
JBrowse link
G PTGR1 prostaglandin reductase 1 ISO protein:increased expression:liver RGD PMID:24853774 RGD:14401713 NCBI chr 9:111,549,722...111,599,647
Ensembl chr 9:111,549,722...111,599,893
JBrowse link
G RAD51 RAD51 recombinase ISO protein:decreased expression:liver RGD PMID:17219426 RGD:2292638 NCBI chr15:40,694,733...40,732,340
Ensembl chr15:40,694,774...40,732,340
JBrowse link
G RB1 RB transcriptional corepressor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17854601 NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
JBrowse link
G RGN regucalcin EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr  X:47,078,443...47,093,313
Ensembl chr  X:47,078,355...47,093,314
JBrowse link
G RIDA reactive intermediate imine deaminase A homolog ISO protein:increased expression:liver (rat) RGD PMID:12939504 RGD:9685719 NCBI chr 8:98,102,344...98,117,171
Ensembl chr 8:98,102,344...98,117,171
JBrowse link
G RRAS2 RAS related 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21147764 NCBI chr11:14,277,920...14,364,506
Ensembl chr11:14,277,922...14,364,506
JBrowse link
G RRM1 ribonucleotide reductase catalytic subunit M1 ISO RGD PMID:15224347 RGD:2316863 NCBI chr11:4,094,685...4,138,932
Ensembl chr11:4,094,707...4,138,932
JBrowse link
G RXRA retinoid X receptor alpha ISO mRNA, protein:decreased expression:liver RGD PMID:17786350 RGD:1643105 NCBI chr 9:134,326,455...134,440,585
Ensembl chr 9:134,317,098...134,440,585
JBrowse link
G SERPINA1 serpin family A member 1 ISO RGD PMID:10569800 RGD:1626391 NCBI chr14:94,376,747...94,390,635
Ensembl chr14:94,376,747...94,390,693
JBrowse link
G SLC31A1 solute carrier family 31 member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23792645 NCBI chr 9:113,221,544...113,264,492
Ensembl chr 9:113,221,544...113,264,492
JBrowse link
G SLC7A5 solute carrier family 7 member 5 ISO mRNA:increased expression:liver RGD PMID:17498859 RGD:151357003 NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,023...87,869,507
JBrowse link
G SOCS1 suppressor of cytokine signaling 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:15197228 NCBI chr16:11,254,417...11,256,204
Ensembl chr16:11,254,417...11,256,204
JBrowse link
G SOX4 SRY-box transcription factor 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21147764 NCBI chr 6:21,593,751...21,598,619
Ensembl chr 6:21,593,751...21,598,619
JBrowse link
G SPP1 secreted phosphoprotein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
JBrowse link
G SQLE squalene epoxidase EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283
JBrowse link
G STAT3 signal transducer and activator of transcription 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26297436 PMID:28100771 NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,540
JBrowse link
G TEK TEK receptor tyrosine kinase EXP CTD Direct Evidence: marker/mechanism CTD PMID:11956651 NCBI chr 9:27,109,141...27,230,178
Ensembl chr 9:27,109,141...27,230,174
JBrowse link
G TGFA transforming growth factor alpha ISO
EXP
protein:increased expression:liver
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:9079223 PMID:16734725 RGD:2317490 NCBI chr 2:70,447,284...70,553,826
Ensembl chr 2:70,447,284...70,554,193
JBrowse link
G TGFB1 transforming growth factor beta 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28100771 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
JBrowse link
G TK1 thymidine kinase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11420682 NCBI chr17:78,174,079...78,187,204
Ensembl chr17:78,174,091...78,187,233
JBrowse link
G TNF tumor necrosis factor disease_progression
treatment
EXP
ISO
IMP
CTD Direct Evidence: marker/mechanism
protein:increased expression:blood serum (mouse)
Morris hepatoma
CTD
RGD
PMID:28100771 PMID:26569409 PMID:9063767 RGD:11344640, RGD:14696818 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TNFRSF10B TNF receptor superfamily member 10b EXP CTD Direct Evidence: therapeutic CTD PMID:18079962 NCBI chr 8:23,020,133...23,069,031
Ensembl chr 8:23,020,133...23,069,031
JBrowse link
G TP53 tumor protein p53 ISO
EXP
CTD Direct Evidence: marker/mechanism CTD PMID:10626228 PMID:28100771 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
G TSC22D1 TSC22 domain family member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:15833021 PMID:17533171 NCBI chr13:44,432,143...44,577,344
Ensembl chr13:44,432,143...44,577,147
JBrowse link
G VIM vimentin ISO RGD PMID:19199359 RGD:6480440 NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
JBrowse link
G XDH xanthine dehydrogenase ISO protein:decreased expression:liver RGD PMID:3460692 RGD:13210515 NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
JBrowse link
Experimental Melanoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACSS1 acyl-CoA synthetase short chain family member 1 treatment IMP RGD PMID:27539851 RGD:13831304 NCBI chr20:25,006,237...25,058,139
Ensembl chr20:25,006,230...25,058,980
JBrowse link
G ACSS2 acyl-CoA synthetase short chain family member 2 treatment IMP RGD PMID:27539851 RGD:13831304 NCBI chr20:34,874,989...34,927,959
Ensembl chr20:34,872,146...34,927,962
JBrowse link
G ANTXR1 ANTXR cell adhesion molecule 1 treatment ISO
IDA
RGD PMID:19622764 PMID:19609240 RGD:9684925, RGD:9684939 NCBI chr 2:69,013,144...69,249,327
Ensembl chr 2:69,013,176...69,249,327
JBrowse link
G BRAF B-Raf proto-oncogene, serine/threonine kinase EXP CTD Direct Evidence: marker/mechanism CTD PMID:29179997 PMID:29438700 NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
JBrowse link
G CALR calreticulin EXP CTD Direct Evidence: therapeutic CTD PMID:16388313 NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
JBrowse link
G CCL20 C-C motif chemokine ligand 20 treatment ISO RGD PMID:14500387 RGD:7483600 NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
JBrowse link
G CTLA4 cytotoxic T-lymphocyte associated protein 4 treatment IMP RGD PMID:24041689 RGD:7411680 NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
JBrowse link
G EGR1 early growth response 1 ISO mRNA, protein:increased expression:salivary gland (mouse) RGD PMID:19517020 RGD:5131885 NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
JBrowse link
G ESR2 estrogen receptor 2 severity ISO RGD PMID:20354658 RGD:8694122 NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
JBrowse link
G HGF hepatocyte growth factor ISO RGD PMID:9823327 RGD:8548620 NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
JBrowse link
G IFNB1 interferon beta 1 EXP CTD Direct Evidence: therapeutic CTD PMID:16417267 NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942
JBrowse link
G IKBKB inhibitor of nuclear factor kappa B kinase subunit beta IMP RGD PMID:19276165 RGD:7495758 NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
JBrowse link
G IL18 interleukin 18 treatment ISO RGD PMID:12230493 PMID:17411412 RGD:8655870, RGD:8655901 NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
JBrowse link
G IL1A interleukin 1 alpha treatment ISO RGD PMID:8061895 RGD:7794735 NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
JBrowse link
G IL1B interleukin 1 beta IDA RGD PMID:1966551 RGD:7401226 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G IL2 interleukin 2 IDA RGD PMID:11884028 RGD:8662950 NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
JBrowse link
G KDM1A lysine demethylase 1A EXP CTD Direct Evidence: marker/mechanism CTD PMID:29438700 NCBI chr 1:23,019,468...23,083,689
Ensembl chr 1:23,019,443...23,083,689
JBrowse link
G KDM4C lysine demethylase 4C EXP CTD Direct Evidence: marker/mechanism CTD PMID:29438700 NCBI chr 9:6,720,863...7,175,648
Ensembl chr 9:6,720,863...7,175,648
JBrowse link
G MC1R melanocortin 1 receptor ISO RGD PMID:20126537 RGD:5687319 NCBI chr16:89,918,862...89,920,972
Ensembl chr16:89,912,119...89,920,973
JBrowse link
G PDCD1 programmed cell death 1 treatment ISO RGD PMID:19208793 RGD:9589070 NCBI chr 2:241,849,884...241,858,894
Ensembl chr 2:241,849,884...241,858,894
JBrowse link
G PTEN phosphatase and tensin homolog EXP CTD Direct Evidence: marker/mechanism CTD PMID:29179997 NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
JBrowse link
G PXN paxillin EXP CTD Direct Evidence: marker/mechanism CTD PMID:18492274 NCBI chr12:120,210,447...120,265,730
Ensembl chr12:120,210,439...120,265,771
JBrowse link
G TERT telomerase reverse transcriptase treatment ISO RGD PMID:19903903 RGD:11038656 NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
JBrowse link
Experimental Sarcoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AGPS alkylglycerone phosphate synthase ISO RGD PMID:7407223 RGD:1598794 NCBI chr 2:177,392,773...177,543,834
Ensembl chr 2:177,392,746...177,567,024
JBrowse link
G ALB albumin ISO mRNA,protein:decreased expression:liver,serum: RGD PMID:1900492 RGD:11035284 NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
JBrowse link
G EPO erythropoietin EXP CTD Direct Evidence: therapeutic CTD PMID:9743294 NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
JBrowse link
G IFNG interferon gamma treatment ISO RGD PMID:2119881 RGD:10755752 NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
JBrowse link
G KRAS KRAS proto-oncogene, GTPase ISO A to T transversion; Gln to His substitution RGD PMID:11295286 RGD:1598680 NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936
JBrowse link
G NRAS NRAS proto-oncogene, GTPase ISO DNA:transversion:exon p.Q61L (human) RGD PMID:11295286 RGD:1598680 NCBI chr 1:114,704,469...114,716,771
Ensembl chr 1:114,704,469...114,716,771
JBrowse link
G SLC6A14 solute carrier family 6 member 14 ISO mRNA, protein:increased expression:brush border epithelial cell RGD PMID:17006743 RGD:1625275 NCBI chr  X:116,436,606...116,461,458
Ensembl chr  X:116,436,606...116,461,458
JBrowse link
Mammary Neoplasms, Experimental term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 ISO RGD PMID:19654309 RGD:2315553 NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
JBrowse link
G ABCG2 ATP binding cassette subfamily G member 2 (Junior blood group) EXP CTD Direct Evidence: therapeutic CTD PMID:22767648 NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
JBrowse link
G ACSL1 acyl-CoA synthetase long chain family member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 4:184,755,595...184,826,594
Ensembl chr 4:184,755,595...184,826,818
JBrowse link
G ACTB actin beta EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902
JBrowse link
G ACTG1 actin gamma 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr17:81,509,971...81,512,799
Ensembl chr17:81,509,413...81,523,847
JBrowse link
G ACTN4 actinin alpha 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr19:38,647,649...38,731,589
Ensembl chr19:38,647,649...38,731,589
JBrowse link
G ADCY5 adenylate cyclase 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 3:123,282,296...123,449,090
Ensembl chr 3:123,282,296...123,449,090
JBrowse link
G ADIPOQ adiponectin, C1Q and collagen domain containing disease_progression
treatment
ISO RGD PMID:19447866 PMID:22246620 RGD:8694414, RGD:8694468 NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
JBrowse link
G AFP alpha fetoprotein EXP CTD Direct Evidence: therapeutic CTD PMID:16322315 NCBI chr 4:73,436,221...73,456,174
Ensembl chr 4:73,431,138...73,456,174
JBrowse link
G AGT angiotensinogen treatment IDA RGD PMID:20837666 RGD:5129167 NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
JBrowse link
G AGTR1 angiotensin II receptor type 1 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:8389152 PMID:18421211 RGD:2292665 NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
JBrowse link
G AGTR2 angiotensin II receptor type 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:8389152 NCBI chr  X:116,170,744...116,174,974
Ensembl chr  X:116,170,744...116,174,974
JBrowse link
G AKT1 AKT serine/threonine kinase 1 ISO RGD PMID:17210696 RGD:2315600 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
JBrowse link
G AKT2 AKT serine/threonine kinase 2 ISO RGD PMID:17210696 RGD:2315600 NCBI chr19:40,230,317...40,285,345
Ensembl chr19:40,230,317...40,285,536
JBrowse link
G ALCAM activated leukocyte cell adhesion molecule EXP
ISO
CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 PMID:16316942 RGD:2306898 NCBI chr 3:105,366,909...105,576,900
Ensembl chr 3:105,366,909...105,576,900
JBrowse link
G ALOX5AP arachidonate 5-lipoxygenase activating protein ISO mRNA:increased expression:mammary gland tumor (rat) RGD PMID:18959458 RGD:2313895 NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426
JBrowse link
G ANTXR1 ANTXR cell adhesion molecule 1 disease_progression IDA RGD PMID:22085271 RGD:9684855 NCBI chr 2:69,013,144...69,249,327
Ensembl chr 2:69,013,176...69,249,327
JBrowse link
G ANXA1 annexin A1 ISO
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:12376462 PMID:16316942 PMID:16316942 RGD:2306898 NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,393
JBrowse link
G ANXA4 annexin A4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 2:69,643,808...69,827,112
Ensembl chr 2:69,644,425...69,827,112
JBrowse link
G APAF1 apoptotic peptidase activating factor 1 ISO RGD PMID:14973070 RGD:2325748 NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,290...98,735,433
JBrowse link
G APOE apolipoprotein E ISO RGD PMID:22469977 RGD:7771597 NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
JBrowse link
G AQP1 aquaporin 1 (Colton blood group) EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 7:30,911,853...30,925,516
Ensembl chr 7:30,911,853...30,925,517
JBrowse link
G AR androgen receptor ISO RGD PMID:12150826 RGD:6482679 NCBI chr  X:67,544,021...67,730,619
Ensembl chr  X:67,544,021...67,730,619
JBrowse link
G AREG amphiregulin ISO mRNA:increased expression:mammary gland
protein:increased expression:mammary gland
RGD PMID:18421211 PMID:10225449 RGD:2292665, RGD:2292663 NCBI chr 4:74,445,136...74,455,005
Ensembl chr 4:74,445,136...74,455,005
JBrowse link
G ARHGAP5 Rho GTPase activating protein 5 disease_progression ISO mRNA:increased expression:mammary gland RGD PMID:10939588 PMID:19703301 RGD:2316183, RGD:126848766 NCBI chr14:32,075,880...32,159,728
Ensembl chr14:32,076,114...32,159,728
JBrowse link
G ATP5IF1 ATP synthase inhibitory factor subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 1:28,236,124...28,238,100
Ensembl chr 1:28,236,109...28,246,906
JBrowse link
G AURKA aurora kinase A EXP CTD Direct Evidence: marker/mechanism CTD PMID:12124350 NCBI chr20:56,369,390...56,392,215
Ensembl chr20:56,369,389...56,392,337
JBrowse link
G BAD BCL2 associated agonist of cell death treatment
severity
ISO RGD PMID:23404339 PMID:20732338 RGD:10053670, RGD:10053708 NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
JBrowse link
G BAK1 BCL2 antagonist/killer 1 ISO RGD PMID:19222350 RGD:2315700 NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
JBrowse link
G BARD1 BRCA1 associated RING domain 1 ISO RGD PMID:18443292 RGD:2293149 NCBI chr 2:214,725,646...214,809,683
Ensembl chr 2:214,725,646...214,809,683
JBrowse link
G BASP1 brain abundant membrane attached signal protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 5:17,216,823...17,276,834
Ensembl chr 5:17,065,598...17,276,843
JBrowse link
G BAX BCL2 associated X, apoptosis regulator treatment
severity
ISO RGD PMID:23404339 PMID:20732338 RGD:10053670, RGD:10053708 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G BCL2 BCL2 apoptosis regulator treatment ISO RGD PMID:23404339 PMID:22668016 RGD:10053670, RGD:10054128 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G BCL2L1 BCL2 like 1 treatment ISO RGD PMID:23404339 RGD:10053670 NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
JBrowse link
G BGN biglycan EXP CTD Direct Evidence: marker/mechanism CTD PMID:35234341 NCBI chr  X:153,494,980...153,509,546
Ensembl chr  X:153,494,980...153,509,546
JBrowse link
G BRCA1 BRCA1 DNA repair associated susceptibility IMP
ISO
EXP
Protein:decrease expression
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:12203372 PMID:22767648 PMID:17505536 PMID:12203372 PMID:18443292 RGD:2293155, RGD:1599502, RGD:2293149 NCBI chr17:43,044,295...43,125,364
Ensembl chr17:43,044,295...43,170,245
JBrowse link
G BST2 bone marrow stromal cell antigen 2 disease_progression ISO RGD PMID:23806386 PMID:23806386 RGD:14398495, RGD:14398495 NCBI chr19:17,402,939...17,405,630
Ensembl chr19:17,402,939...17,405,630
JBrowse link
G CA9 carbonic anhydrase 9 ISO RGD PMID:17280655 RGD:2293194 NCBI chr 9:35,673,928...35,681,159
Ensembl chr 9:35,673,928...35,681,159
JBrowse link
G CAD carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase disease_progression ISO protein:increased expression:mammary gland RGD PMID:6030068 RGD:2303540 NCBI chr 2:27,217,369...27,243,943
Ensembl chr 2:27,217,369...27,243,943
JBrowse link
G CAPZB capping actin protein of muscle Z-line subunit beta EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 1:19,338,775...19,485,539
Ensembl chr 1:19,338,775...19,485,539
JBrowse link
G CASK calcium/calmodulin dependent serine protein kinase EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr  X:41,514,934...41,923,554
Ensembl chr  X:41,514,934...41,923,554
JBrowse link
G CASP1 caspase 1 treatment ISO RGD PMID:10557324 RGD:2315886 NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
JBrowse link
G CASP3 caspase 3 treatment
severity
ISO RGD PMID:23404339 PMID:20732338 PMID:26699876 RGD:10053670, RGD:10053708, RGD:13782283 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
JBrowse link
G CASP7 caspase 7 treatment ISO
IMP
RGD PMID:23404339 PMID:26699876 PMID:23979166 RGD:10053670, RGD:13782283, RGD:13209143 NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
JBrowse link
G CASP8 caspase 8 severity ISO RGD PMID:20732338 RGD:10053708 NCBI chr 2:201,233,443...201,287,711
Ensembl chr 2:201,233,443...201,361,836
JBrowse link
G CASP9 caspase 9 severity
treatment
ISO RGD PMID:17297389 PMID:20012353 PMID:20732338 PMID:26699876 RGD:2315933, RGD:2315928, RGD:10053708, RGD:13782283 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
JBrowse link
G CAV1 caveolin 1 onset
treatment
ISO
IMP
protein:decreased expression:mammary gland RGD PMID:9685399 PMID:15355971 PMID:15334058 RGD:2289100, RGD:2289106, RGD:8661780 NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,524,994...116,561,179
JBrowse link
G CCNA2 cyclin A2 ISO protein:increased expression:mammary gland RGD PMID:10713672 RGD:2293347 NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
JBrowse link
G CCNB1 cyclin B1 ISO RGD PMID:11146550 RGD:2315939 NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
JBrowse link
G CCND1 cyclin D1 ISO
EXP
protein:decreased expression:mammary gland
CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
mRNA, protein:increased expression:mammary gland (rat)
CTD
RGD
PMID:12376462 PMID:14522882 PMID:16316942 PMID:17440082 PMID:12602925 More... RGD:2296037, RGD:2289337, RGD:2289336, RGD:2306898, RGD:2292404 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
JBrowse link
G CCND3 cyclin D3 ISO mRNA, protein:increased expression:mammary gland RGD PMID:16311245 PMID:12853979 RGD:2316020, RGD:2316015 NCBI chr 6:41,934,933...42,048,894
Ensembl chr 6:41,934,934...42,050,357
JBrowse link
G CCNE1 cyclin E1 ISO protein:decreased expression:mammary gland RGD PMID:12649181 PMID:12602925 RGD:2289336, RGD:2289337 NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
JBrowse link
G CCNH cyclin H ISO
EXP
mRNA:increased expression:mammary gland
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:12606953 PMID:12606953 RGD:9590264 NCBI chr 5:87,311,471...87,412,930
Ensembl chr 5:87,318,416...87,412,930
JBrowse link
G CCR3 C-C motif chemokine receptor 3 ISO RGD PMID:21621198 RGD:6893427 NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
JBrowse link
G CCR5 C-C motif chemokine receptor 5 IMP RGD PMID:14597737 PMID:22637726 RGD:8551810, RGD:8551813 NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
JBrowse link
G CD274 CD274 molecule treatment ISO RGD PMID:29043842 RGD:40886270 NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
JBrowse link
G CD40 CD40 molecule ISO RGD PMID:21137078 RGD:8547744 NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
JBrowse link
G CD44 CD44 molecule (Indian blood group) EXP CTD Direct Evidence: marker/mechanism CTD PMID:21283680 NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
JBrowse link
G CDC25A cell division cycle 25A ISO
IMP
RGD PMID:16951165 PMID:17283130 PMID:17638870 RGD:2771824, RGD:2764000, RGD:2754551 NCBI chr 3:48,157,146...48,188,417
Ensembl chr 3:48,157,146...48,188,417
JBrowse link
G CDC42 cell division cycle 42 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 1:22,052,709...22,101,360
Ensembl chr 1:22,052,627...22,101,360
JBrowse link
G CDH1 cadherin 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
JBrowse link
G CDH13 cadherin 13 severity ISO RGD PMID:18316604 PMID:18316604 RGD:2293540, RGD:2293540 NCBI chr16:82,626,969...83,800,640
Ensembl chr16:82,626,965...83,800,640
JBrowse link
G CDK2 cyclin dependent kinase 2 ISO RGD PMID:16924466 RGD:2293558 NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
JBrowse link
G CDK4 cyclin dependent kinase 4 susceptibility ISO
EXP
protein:increased expression:mammary gland
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:12376462 PMID:14522882 PMID:25221644 PMID:14522882 PMID:16413469 RGD:2293581, RGD:2293577 NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
JBrowse link
G CDK6 cyclin dependent kinase 6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25221644 NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573
JBrowse link
G CDKL2 cyclin dependent kinase like 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25333262 NCBI chr 4:75,576,496...75,630,528
Ensembl chr 4:75,576,496...75,630,716
JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B treatment ISO protein:increased expression:mammary gland RGD PMID:15844214 PMID:22651929 RGD:2293626, RGD:10045559 NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A disease_progression ISO RGD PMID:18060046 PMID:20681787 RGD:2289674, RGD:8552689 NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
JBrowse link
G CDS1 CDP-diacylglycerol synthase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 4:84,583,127...84,651,334
Ensembl chr 4:84,583,127...84,651,334
JBrowse link
G CLU clusterin disease_progression IMP RGD PMID:23099883 RGD:8699504 NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
JBrowse link
G CNN3 calponin 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:94,896,957...94,927,110
Ensembl chr 1:94,896,949...94,927,223
JBrowse link
G COL18A1 collagen type XVIII alpha 1 chain severity ISO RGD PMID:10766159 RGD:70690 NCBI chr21:45,405,165...45,513,720
Ensembl chr21:45,405,165...45,513,720
JBrowse link
G COL5A1 collagen type V alpha 1 chain EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 9:134,641,803...134,844,843
Ensembl chr 9:134,641,803...134,844,843
JBrowse link
G CSF1 colony stimulating factor 1 IMP RGD PMID:15205327 RGD:2293710 NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992
JBrowse link
G CSN2 casein beta EXP
ISO
CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:9879772 PMID:16316942 PMID:16316942 RGD:2306898 NCBI chr 4:69,955,256...69,965,728
Ensembl chr 4:69,955,256...69,965,728
JBrowse link
G CSN3 casein kappa EXP
ISO
CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 PMID:16316942 RGD:2306898 NCBI chr 4:70,238,381...70,251,432
Ensembl chr 4:70,238,382...70,251,474
JBrowse link
G CSNK2A1 casein kinase 2 alpha 1 ISO RGD PMID:11827167 PMID:11827167 RGD:727632, RGD:727632 NCBI chr20:472,498...543,790
Ensembl chr20:472,498...543,835
JBrowse link
G CTNNB1 catenin beta 1 ISO DNA:missense mutations: :p.S33Y, p.S45F
protein:increased expression:mammary gland
RGD PMID:18060046 PMID:17510243 RGD:2289674, RGD:2289816 NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
JBrowse link
G DBI diazepam binding inhibitor, acyl-CoA binding protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 2:119,366,977...119,372,543
Ensembl chr 2:119,366,924...119,372,550
JBrowse link
G DDR1 discoidin domain receptor tyrosine kinase 1 EXP
ISO
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:21283680 PMID:29298894 RGD:151347446 NCBI chr 6:30,880,970...30,900,156
Ensembl chr 6:30,876,421...30,900,156
JBrowse link
G DES desmin EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 2:219,418,377...219,426,734
Ensembl chr 2:219,418,377...219,426,735
JBrowse link
G DIO1 iodothyronine deiodinase 1 ISO RGD PMID:11765219 RGD:727335 NCBI chr 1:53,894,187...53,911,086
Ensembl chr 1:53,891,239...53,911,086
JBrowse link
G DNMT3B DNA methyltransferase 3 beta treatment ISO RGD PMID:24447120 RGD:9588304 NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
JBrowse link
G DUSP1 dual specificity phosphatase 1 treatment IEP RGD PMID:20837666 RGD:5129167 NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
JBrowse link
G DUSP6 dual specificity phosphatase 6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501
JBrowse link
G EEF1A1 eukaryotic translation elongation factor 1 alpha 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 6:73,515,750...73,521,032
Ensembl chr 6:73,489,308...73,525,587
JBrowse link
G EFEMP1 EGF containing fibulin extracellular matrix protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 2:55,865,967...55,923,782
Ensembl chr 2:55,865,967...55,924,139
JBrowse link
G EGFR epidermal growth factor receptor IMP
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:2523869 PMID:8603490 PMID:17203220 RGD:2289979 NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
JBrowse link
G EIF5A eukaryotic translation initiation factor 5A EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr17:7,306,999...7,312,463
Ensembl chr17:7,306,999...7,312,463
JBrowse link
G ENO1 enolase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190
JBrowse link
G EPCAM epithelial cell adhesion molecule EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 2:47,369,311...47,387,020
Ensembl chr 2:47,345,158...47,387,601
JBrowse link
G EPHX1 epoxide hydrolase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
JBrowse link
G EPO erythropoietin treatment ISO RGD PMID:12118093 RGD:11041669 NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
JBrowse link
G EPOR erythropoietin receptor treatment ISO RGD PMID:12118093 RGD:11041669 NCBI chr19:11,377,207...11,384,314
Ensembl chr19:11,377,207...11,384,342
JBrowse link
G ERBB2 erb-b2 receptor tyrosine kinase 2 IMP
ISO
EXP
CTD Direct Evidence: marker/mechanism
Androgen-dependent
CTD
RGD
PMID:8603490 PMID:25221644 PMID:17203220 PMID:1913683 PMID:12150826 RGD:2289979, RGD:2289920, RGD:6482679 NCBI chr17:39,688,094...39,728,658
Ensembl chr17:39,687,914...39,730,426
JBrowse link
G ERBB3 erb-b2 receptor tyrosine kinase 3 IMP RGD PMID:17203220 RGD:2289979 NCBI chr12:56,080,108...56,103,505
Ensembl chr12:56,076,799...56,103,505
JBrowse link
G ERBB4 erb-b2 receptor tyrosine kinase 4 IMP RGD PMID:17203220 RGD:2289979 NCBI chr 2:211,375,717...212,538,802
Ensembl chr 2:211,375,717...212,538,841
JBrowse link
G ESR1 estrogen receptor 1 susceptibility ISO
EXP
CTD Direct Evidence: marker/mechanism
protein:increased expression:epithelial cell, nucleus
CTD
RGD
PMID:15637090 PMID:18055862 PMID:11759285 PMID:15637090 RGD:2290019, RGD:8553057, RGD:8552983 NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
JBrowse link
G ESR2 estrogen receptor 2 treatment ISO
EXP
protein:increased expression:epithelial cell, nucleus
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:15637090 PMID:24078029 PMID:15637090 RGD:7364911, RGD:8552983 NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
JBrowse link
G EZR ezrin EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 6:158,765,748...158,819,368
Ensembl chr 6:158,765,741...158,819,368
JBrowse link
G F11R F11 receptor IEP RGD PMID:22120722 RGD:7488922 NCBI chr 1:160,995,211...161,021,152
Ensembl chr 1:160,995,211...161,021,343
JBrowse link
G FABP4 fatty acid binding protein 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 8:81,478,419...81,483,233
Ensembl chr 8:81,478,419...81,483,236
JBrowse link
G FAS Fas cell surface death receptor ISO RGD PMID:18094967 RGD:2290047 NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
JBrowse link
G FBXO10 F-box protein 10 ISO RGD PMID:17404222 RGD:1601189 NCBI chr 9:37,510,892...37,576,380
Ensembl chr 9:37,510,892...37,576,380
JBrowse link
G FGF10 fibroblast growth factor 10 ISO mRNA:increased expression:mammary gland RGD PMID:18421211 RGD:2292665 NCBI chr 5:44,300,247...44,389,420
Ensembl chr 5:44,300,247...44,389,706
JBrowse link
G FGF7 fibroblast growth factor 7 ISO RGD PMID:9000125 RGD:2301094 NCBI chr15:49,423,242...49,488,775
Ensembl chr15:49,423,237...49,488,775
JBrowse link
G FGF8 fibroblast growth factor 8 ISO RGD PMID:9840935 RGD:2301098 NCBI chr10:101,770,109...101,780,369
Ensembl chr10:101,770,109...101,780,371
JBrowse link
G FLT3 fms related receptor tyrosine kinase 3 ISO RGD PMID:10498246 RGD:2302211 NCBI chr13:28,003,274...28,100,576
Ensembl chr13:28,003,274...28,100,592
JBrowse link
G FN1 fibronectin 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
JBrowse link
G FRMPD1 FERM and PDZ domain containing 1 ISO RGD PMID:17404222 RGD:1601189 NCBI chr 9:37,603,229...37,746,904
Ensembl chr 9:37,650,954...37,746,904
JBrowse link
G FURIN furin, paired basic amino acid cleaving enzyme EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr15:90,868,588...90,883,457
Ensembl chr15:90,868,588...90,883,564
JBrowse link
G G0S2 G0/G1 switch 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 1:209,675,412...209,676,390
Ensembl chr 1:209,675,412...209,676,390
JBrowse link
G GATA3 GATA binding protein 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr10:8,045,333...8,075,198
Ensembl chr10:8,045,378...8,075,198
JBrowse link
G GATM glycine amidinotransferase EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr15:45,361,124...45,402,227
Ensembl chr15:45,361,124...45,402,327
JBrowse link
G GDA guanine deaminase EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 9:72,114,608...72,259,869
Ensembl chr 9:72,114,595...72,257,193
JBrowse link
G GGT1 gamma-glutamyltransferase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
JBrowse link
G GH1 growth hormone 1 treatment ISO
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:12082019 PMID:15528971 PMID:17584969 PMID:17584969 PMID:6139974 RGD:2315650, RGD:11352806 NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839
JBrowse link
G GLYCAM1 glycosylation dependent cell adhesion molecule 1 (pseudogene) EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr12:54,608,187...54,610,462
Ensembl chr12:54,608,187...54,610,462
JBrowse link
G GNAI2 G protein subunit alpha i2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 3:50,227,068...50,263,358
Ensembl chr 3:50,226,292...50,259,362
JBrowse link
G GSK3B glycogen synthase kinase 3 beta treatment ISO RGD PMID:28810530 RGD:13792729 NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
JBrowse link
G GSN gelsolin ISO mRNA:decreased expression RGD PMID:8895730 RGD:1599869 NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843
JBrowse link
G GSS glutathione synthetase EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr20:34,928,432...34,956,027
Ensembl chr20:34,928,432...34,956,027
JBrowse link
G H19 H19 imprinted maternally expressed transcript ISO RGD PMID:15170812 RGD:1642758 NCBI chr11:1,995,176...2,001,466
Ensembl chr11:1,995,166...2,001,470
JBrowse link
G H2AX H2A.X variant histone treatment ISO RGD PMID:22384017 RGD:7240549 NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
JBrowse link
G H3-3B H3.3 histone B ISO CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr17:75,776,434...75,779,779
Ensembl chr17:75,776,434...75,785,893
JBrowse link
G HBA1 hemoglobin subunit alpha 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr16:176,680...177,522
Ensembl chr16:176,680...177,522
JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha treatment ISO RGD PMID:17280655 RGD:2293194 NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
JBrowse link
G HMOX1 heme oxygenase 1 treatment ISO
EXP
CTD Direct Evidence: therapeutic CTD
RGD
PMID:16319139 PMID:23215791 RGD:10755708 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
JBrowse link
G HNRNPA1 heterogeneous nuclear ribonucleoprotein A1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr12:54,280,726...54,287,087
Ensembl chr12:54,280,193...54,287,088
JBrowse link
G HNRNPAB heterogeneous nuclear ribonucleoprotein A/B EXP CTD Direct Evidence: marker/mechanism CTD PMID:15538050 NCBI chr 5:178,204,533...178,211,163
Ensembl chr 5:178,204,533...178,211,163
JBrowse link
G HP haptoglobin treatment ISO RGD PMID:23880232 RGD:11041861 NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
JBrowse link
G HRAS HRas proto-oncogene, GTPase ISO
EXP
DNA:mutation: :p.G12E (rat)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:8185828 PMID:11376698 PMID:19652463 RGD:2314834 NCBI chr11:532,242...535,576
Ensembl chr11:532,242...537,321
JBrowse link
G ID1 inhibitor of DNA binding 1, HLH protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:21283680 NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
JBrowse link
G ID3 inhibitor of DNA binding 3, HLH protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:23,557,926...23,559,501
Ensembl chr 1:23,557,926...23,559,501
JBrowse link
G ID4 inhibitor of DNA binding 4, HLH protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:14633621 NCBI chr 6:19,837,370...19,842,197
Ensembl chr 6:19,837,370...19,842,197
JBrowse link
G IGF1 insulin like growth factor 1 ISO
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:15217511 PMID:15528971 PMID:17584969 PMID:23342276 RGD:8549490 NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
JBrowse link
G IL10 interleukin 10 EXP CTD Direct Evidence: marker/mechanism CTD PMID:14999141 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
JBrowse link
G IL18BP interleukin 18 binding protein ISO mRNA:increased expression:mammary gland RGD PMID:18959458 RGD:2313895 NCBI chr11:71,998,909...72,008,200
Ensembl chr11:71,998,613...72,007,315
JBrowse link
G IL1RN interleukin 1 receptor antagonist treatment IDA human protein in a mouse model RGD PMID:21890879 RGD:6771361 NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
JBrowse link
G IL6ST interleukin 6 cytokine family signal transducer EXP CTD Direct Evidence: marker/mechanism CTD PMID:12606953 NCBI chr 5:55,935,095...55,994,963
Ensembl chr 5:55,935,095...55,995,022
JBrowse link
G ILK integrin linked kinase IDA late onset development of tumors in transgenic mice overexpressing human ILK in mammary glands RGD PMID:11704830 RGD:2301733 NCBI chr11:6,603,774...6,610,870
Ensembl chr11:6,603,708...6,610,874
JBrowse link
G INSIG1 insulin induced gene 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
JBrowse link
G ITGB3 integrin subunit beta 3 ISO protein:increased expression:mammary gland: RGD PMID:22022542 RGD:8693386 NCBI chr17:47,253,827...47,313,743
Ensembl chr17:47,253,827...47,313,743
JBrowse link
G KDR kinase insert domain receptor ISO
IMP
RGD PMID:15170218 PMID:19888452 RGD:2291936, RGD:5684399 NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
JBrowse link
G KIT KIT proto-oncogene, receptor tyrosine kinase ISO DNA:mutation (rat) RGD PMID:18445266 RGD:2302172 NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,267...54,740,783
JBrowse link
G KITLG KIT ligand EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr12:88,492,793...88,580,471
Ensembl chr12:88,492,793...88,580,851
JBrowse link
G KRT5 keratin 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr12:52,514,575...52,520,394
Ensembl chr12:52,514,575...52,520,530
JBrowse link
G KRT7 keratin 7 ISO RGD PMID:8570173 RGD:2317439 NCBI chr12:52,233,243...52,255,853
Ensembl chr12:52,232,520...52,252,186
JBrowse link
G KRT71 keratin 71 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr12:52,543,909...52,553,145
Ensembl chr12:52,543,909...52,553,145
JBrowse link
G LEP leptin treatment ISO RGD PMID:22246620 RGD:8694468 NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
JBrowse link
G LGALS7 galectin 7 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr19:38,770,968...38,773,517
Ensembl chr19:38,789,200...38,791,754
Ensembl chr19:38,789,200...38,791,754
JBrowse link
G LHCGR luteinizing hormone/choriogonadotropin receptor ISO mRNA:splice variant (rat) RGD PMID:15044717 RGD:2302177 NCBI chr 2:48,686,774...48,755,724
Ensembl chr 2:48,686,774...48,755,730
JBrowse link
G LIN7A lin-7 homolog A, crumbs cell polarity complex component EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr12:80,792,520...80,937,934
Ensembl chr12:80,792,520...80,937,934
JBrowse link
G LNPEP leucyl and cystinyl aminopeptidase ISO
EXP
protein:increased expression:serum
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16619500 PMID:16619500 RGD:1582109 NCBI chr 5:96,936,080...97,037,513
Ensembl chr 5:96,935,394...97,037,513
JBrowse link
G LPL lipoprotein lipase EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
JBrowse link
G LSR lipolysis stimulated lipoprotein receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr19:35,249,002...35,267,964
Ensembl chr19:35,248,330...35,267,964
JBrowse link
G MAP2K3 mitogen-activated protein kinase kinase 3 IMP RGD PMID:24233520 RGD:7495808 NCBI chr17:21,284,711...21,315,240
Ensembl chr17:21,284,672...21,315,232
JBrowse link
G MAP2K7 mitogen-activated protein kinase kinase 7 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21317887 NCBI chr19:7,903,877...7,914,478
Ensembl chr19:7,903,843...7,914,478
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 treatment ISO RGD PMID:29435821 RGD:13800872 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 treatment ISO RGD PMID:29435821 RGD:13800872 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
JBrowse link
G MDH2 malate dehydrogenase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 7:76,048,106...76,067,508
Ensembl chr 7:76,048,051...76,067,508
JBrowse link
G MGP matrix Gla protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr12:14,880,864...14,885,854
Ensembl chr12:14,880,864...14,885,857
JBrowse link
G MIF macrophage migration inhibitory factor EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
JBrowse link
G MIR155 microRNA 155 IMP
IDA
RGD PMID:20354188 PMID:29643534 RGD:21079418, RGD:21403681 NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
JBrowse link
G MMP1 matrix metallopeptidase 1 treatment IMP RGD PMID:19622769 RGD:8549722 NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
JBrowse link
G MMP13 matrix metallopeptidase 13 severity ISO RGD PMID:18698413 RGD:2306081 NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732
JBrowse link
G MMP15 matrix metallopeptidase 15 ISO mRNA:increased expression:mammary gland RGD PMID:15895410 RGD:2314949 NCBI chr16:58,025,754...58,046,901
Ensembl chr16:58,025,754...58,046,901
JBrowse link
G MMP2 matrix metallopeptidase 2 treatment ISO
EXP
protein:increased expression:mammary gland
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:28574600 PMID:19725228 PMID:23359979 RGD:2325823, RGD:8657038 NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
JBrowse link
G MMP3 matrix metallopeptidase 3 ISO RGD PMID:10428026 RGD:8662909 NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
JBrowse link
G MMP7 matrix metallopeptidase 7 onset ISO RGD PMID:9850086 RGD:9685350 NCBI chr11:102,520,508...102,530,747
Ensembl chr11:102,520,508...102,530,750
JBrowse link
G MMP9 matrix metallopeptidase 9 treatment ISO
EXP
mRNA, protein:increased expression:mammary gland
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:21283680 PMID:19725228 PMID:23359979 RGD:2325823, RGD:8657038 NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
JBrowse link
G MPZL1 myelin protein zero like 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 1:167,721,982...167,791,919
Ensembl chr 1:167,721,192...167,791,919
JBrowse link
G MRC2 mannose receptor C type 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr17:62,627,670...62,693,597
Ensembl chr17:62,627,670...62,693,597
JBrowse link
G MT-CO1 mitochondrially encoded cytochrome c oxidase I EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr MT:5,904...7,445
Ensembl chr MT:5,904...7,445
JBrowse link
G MTOR mechanistic target of rapamycin kinase ISO RGD PMID:22349822 RGD:10040957 NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
JBrowse link
G MUC1 mucin 1, cell surface associated treatment IDA RGD PMID:23015160 RGD:7349374 NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor treatment ISO RGD PMID:22384017 RGD:7240549 NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
JBrowse link
G NCOA1 nuclear receptor coactivator 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21080969 NCBI chr 2:24,491,254...24,770,702
Ensembl chr 2:24,491,254...24,770,702
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 treatment ISO RGD PMID:22072621 RGD:10412719 NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
JBrowse link
G NOTCH4 notch receptor 4 IAGP RGD PMID:15531924 RGD:2299154 NCBI chr 6:32,194,843...32,224,067
Ensembl chr 6:32,194,843...32,224,067
JBrowse link
G NSMF NMDA receptor synaptonuclear signaling and neuronal migration factor EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 9:137,447,570...137,459,334
Ensembl chr 9:137,447,570...137,459,334
JBrowse link
G NUDT1 nudix hydrolase 1 ISO mRNA:increased expression:mammary gland RGD PMID:12036445 RGD:724605 NCBI chr 7:2,242,226...2,251,145
Ensembl chr 7:2,242,226...2,251,146
JBrowse link
G OXT oxytocin/neurophysin I prepropeptide EXP CTD Direct Evidence: therapeutic CTD PMID:8647655 PMID:15089975 NCBI chr20:3,071,620...3,072,517
Ensembl chr20:3,071,620...3,072,517
JBrowse link
G PADI4 peptidyl arginine deiminase 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:17,308,197...17,364,004
Ensembl chr 1:17,308,195...17,364,004
JBrowse link
G PAK4 p21 (RAC1) activated kinase 4 IMP RGD PMID:20697354 RGD:7775027 NCBI chr19:39,125,786...39,182,816
Ensembl chr19:39,125,770...39,182,816
JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 treatment ISO RGD PMID:23404339 RGD:10053670 NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
JBrowse link
G PCNA proliferating cell nuclear antigen ISO mRNA,protein:increased expression:mammary gland: RGD PMID:2567593 RGD:10448972 NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
JBrowse link
G PCP4 Purkinje cell protein 4 ISO mRNA,protein:increased expression:cytoplasm: RGD PMID:19480007 RGD:9850273 NCBI chr21:39,867,438...39,929,392
Ensembl chr21:39,867,438...39,929,397
JBrowse link
G PDGFA platelet derived growth factor subunit A EXP
ISO
CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:mammary gland (rat)
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:12376462 PMID:16316942 PMID:12376462 PMID:16316942 RGD:2292404, RGD:2306898 NCBI chr 7:497,258...520,700
Ensembl chr 7:497,258...520,296
JBrowse link
G PEBP1 phosphatidylethanolamine binding protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr12:118,136,124...118,145,584
Ensembl chr12:118,136,124...118,145,584
JBrowse link
G PGAM1 phosphoglycerate mutase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr10:97,426,191...97,433,444
Ensembl chr10:97,426,191...97,433,444
JBrowse link
G PGR progesterone receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:15637090 NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
JBrowse link
G PHB1 prohibitin 1 ISO
EXP
mRNA, protein:increased expression:mammary gland
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:12376462 PMID:12376462 RGD:2292404 NCBI chr17:49,404,052...49,414,882
Ensembl chr17:49,404,049...49,414,905
JBrowse link
G PIK3R1 phosphoinositide-3-kinase regulatory subunit 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12606953 NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,740...68,301,821
JBrowse link
G PIN1 peptidylprolyl cis/trans isomerase, NIMA-interacting 1 ISO RGD PMID:22064478 RGD:8693420 NCBI chr19:9,835,318...9,849,689
Ensembl chr19:9,835,257...9,849,689
JBrowse link
G PKM pyruvate kinase M1/2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr15:72,199,029...72,231,591
Ensembl chr15:72,199,029...72,231,819
JBrowse link
G PLAU plasminogen activator, urokinase disease_progression ISO RGD PMID:18052026 RGD:6484140 NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
JBrowse link
G PLK2 polo like kinase 2 EXP
ISO
CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:mammary gland (rat)
CTD
RGD
PMID:12376462 PMID:12376462 RGD:2292404 NCBI chr 5:58,453,982...58,460,086
Ensembl chr 5:58,453,982...58,460,139
JBrowse link
G PPARA peroxisome proliferator activated receptor alpha EXP CTD Direct Evidence: marker/mechanism CTD PMID:11137312 NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
JBrowse link
G PRDX2 peroxiredoxin 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr19:12,796,823...12,801,800
Ensembl chr19:12,796,820...12,801,800
JBrowse link
G PRL prolactin EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
JBrowse link
G PRLR prolactin receptor EXP
ISO
CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 PMID:16316942 RGD:2306898 NCBI chr 5:35,048,756...35,230,487
Ensembl chr 5:35,048,756...35,230,487
JBrowse link
G PSMA4 proteasome 20S subunit alpha 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr15:78,540,405...78,552,417
Ensembl chr15:78,540,405...78,552,417
JBrowse link
G PSME1 proteasome activator subunit 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr14:24,136,194...24,138,962
Ensembl chr14:24,136,163...24,138,967
JBrowse link
G PTBP1 polypyrimidine tract binding protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr19:797,452...812,312
Ensembl chr19:797,075...812,327
JBrowse link
G PTEN phosphatase and tensin homolog onset ISO RGD PMID:18381417 RGD:2292496 NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
JBrowse link
G PTGER1 prostaglandin E receptor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11751431 NCBI chr19:14,472,466...14,475,354
Ensembl chr19:14,472,466...14,475,354
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 ISO mRNA:increased expression:breast RGD PMID:18279516 PMID:18676768 PMID:21623034 RGD:2300130, RGD:2300118, RGD:5135030 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
JBrowse link
G PTK2 protein tyrosine kinase 2 disease_progression ISO
EXP
CTD Direct Evidence: therapeutic CTD
RGD
PMID:24809783 PMID:18056629 PMID:15930288 RGD:2292554, RGD:2292560 NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216
JBrowse link
G PTN pleiotrophin EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 7:137,227,341...137,343,733
Ensembl chr 7:137,227,341...137,343,774
JBrowse link
G PTPRB protein tyrosine phosphatase receptor type B treatment ISO RGD PMID:23899555 RGD:151660352 NCBI chr12:70,515,870...70,637,429
Ensembl chr12:70,515,870...70,637,440
JBrowse link
G RAN RAN, member RAS oncogene family EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr12:130,872,066...130,877,678
Ensembl chr12:130,872,037...130,877,678
JBrowse link
G RASA1 RAS p21 protein activator 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12606953 NCBI chr 5:87,267,883...87,391,916
Ensembl chr 5:87,267,883...87,391,931
JBrowse link
G RASGRF2 Ras protein specific guanine nucleotide releasing factor 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12606953 NCBI chr 5:80,960,363...81,230,162
Ensembl chr 5:80,960,363...81,230,162
JBrowse link
G RB1 RB transcriptional corepressor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:14522882 NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
JBrowse link
G RBP1 retinol binding protein 1 EXP
ISO
CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:mammary gland (rat)
CTD
RGD
PMID:12376462 PMID:12376462 RGD:2292404 NCBI chr 3:139,517,438...139,539,742
Ensembl chr 3:139,517,434...139,539,829
JBrowse link
G RBP4 retinol binding protein 4 EXP
ISO
CTD Direct Evidence: marker/mechanism
mRNA:increased expression:mammary gland (rat)
CTD
RGD
PMID:16316942 PMID:16316942 RGD:2306898 NCBI chr10:93,591,694...93,601,744
Ensembl chr10:93,591,687...93,601,744
JBrowse link
G RCN1 reticulocalbin 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr11:32,091,074...32,105,722
Ensembl chr11:32,091,074...32,105,722
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit ISO protein:decreased expression:peritoneal macrophage RGD PMID:16288051 RGD:2298764 NCBI chr11:65,653,601...65,662,916
Ensembl chr11:65,653,599...65,663,090
JBrowse link
G RELB RELB proto-oncogene, NF-kB subunit ISO RGD PMID:16260626 RGD:7777148 NCBI chr19:45,001,464...45,038,192
Ensembl chr19:45,001,461...45,038,192
JBrowse link
G RNPEP arginyl aminopeptidase ISO
EXP
protein:increased expression:serum
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16619500 PMID:16619500 RGD:1582109 NCBI chr 1:201,982,648...202,006,143
Ensembl chr 1:201,982,372...202,006,147
JBrowse link
G RPL3 ribosomal protein L3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr22:39,312,882...39,319,623
Ensembl chr22:39,312,882...39,320,389
JBrowse link
G RPL6 ribosomal protein L6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr12:112,405,181...112,418,835
Ensembl chr12:112,405,189...112,418,838
JBrowse link
G RPS14 ribosomal protein S14 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 5:150,442,635...150,449,739
Ensembl chr 5:150,442,635...150,449,739
JBrowse link
G RUNX1 RUNX family transcription factor 1 ISO mRNA:increased expression:mammary gland RGD PMID:29435983 RGD:126779584 NCBI chr21:34,787,801...35,049,302
Ensembl chr21:34,787,801...36,004,667
JBrowse link
G RXRA retinoid X receptor alpha ISO RGD PMID:16344269 RGD:1643109 NCBI chr 9:134,326,455...134,440,585
Ensembl chr 9:134,317,098...134,440,585
JBrowse link
G S100A6 S100 calcium binding protein A6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 1:153,534,599...153,535,991
Ensembl chr 1:153,534,599...153,536,244
JBrowse link
G S1PR1 sphingosine-1-phosphate receptor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:101,236,899...101,242,313
Ensembl chr 1:101,236,865...101,243,713
JBrowse link
G SCARB1 scavenger receptor class B member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
JBrowse link
G SCD stearoyl-CoA desaturase EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
JBrowse link
G SELENOP selenoprotein P EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 5:42,799,880...42,811,892
Ensembl chr 5:42,799,880...42,887,392
JBrowse link
G SGK1 serum/glucocorticoid regulated kinase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 6:134,169,256...134,318,112
Ensembl chr 6:134,169,248...134,318,112
JBrowse link
G SLC12A2 solute carrier family 12 member 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 5:128,083,766...128,189,677
Ensembl chr 5:128,083,766...128,189,677
JBrowse link
G SLC25A10 solute carrier family 25 member 10 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr17:81,712,284...81,721,012
Ensembl chr17:81,712,236...81,721,016
JBrowse link
G SNCG synuclein gamma EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr10:86,955,759...86,963,258
Ensembl chr10:86,958,599...86,963,258
JBrowse link
G SNRPD3 small nuclear ribonucleoprotein D3 polypeptide EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr22:24,555,650...24,574,971
Ensembl chr22:24,555,958...24,582,052
JBrowse link
G SOCS1 suppressor of cytokine signaling 1 ISO
IMP
mRNA:increased expression:mammary gland RGD PMID:18381452 PMID:20354188 RGD:2298899, RGD:21079418 NCBI chr16:11,254,417...11,256,204
Ensembl chr16:11,254,417...11,256,204
JBrowse link
G SOCS3 suppressor of cytokine signaling 3 ISO mRNA:increased expression:mammary gland RGD PMID:18381452 RGD:2298899 NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077
JBrowse link
G SOD2 superoxide dismutase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23964924 NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
JBrowse link
G SOX9 SRY-box transcription factor 9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr17:72,121,020...72,126,416
Ensembl chr17:72,121,020...72,126,416
JBrowse link
G SPINT2 serine peptidase inhibitor, Kunitz type 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr19:38,264,573...38,292,615
Ensembl chr19:38,244,035...38,292,615
JBrowse link
G SPP1 secreted phosphoprotein 1 EXP CTD Direct Evidence: therapeutic CTD PMID:15318939 NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
JBrowse link
G SRSF2 serine and arginine rich splicing factor 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr17:76,734,115...76,737,411
Ensembl chr17:76,734,115...76,737,333
JBrowse link
G STAT1 signal transducer and activator of transcription 1 ISO RGD PMID:11325527 RGD:2291895 NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
JBrowse link
G STAT3 signal transducer and activator of transcription 3 ISO
EXP
mRNA:increased expression:mammary gland (rat)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16316942 PMID:17483332 PMID:16316942 RGD:2291914, RGD:2306898 NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,540
JBrowse link
G STAT5A signal transducer and activator of transcription 5A susceptibility ISO
EXP
protein:altered localization:nucleus
mRNA, protein:increased expression:mammary gland (rat)
mRNA:increased expression:mammary gland (rat)
CTD Direct Evidence: marker/mechanism
protein:increased tyrosine phosphorylation:mammary gland
CTD
RGD
PMID:12376462 PMID:15609129 PMID:16316942 PMID:15609129 PMID:20181624 More... RGD:2291932, RGD:151665819, RGD:2292404, RGD:2306898, RGD:2298539, RGD:2291927 NCBI chr17:42,287,547...42,311,943
Ensembl chr17:42,287,547...42,311,943
JBrowse link
G STAT6 signal transducer and activator of transcription 6 ISO RGD PMID:11086031 RGD:2298563 NCBI chr12:57,095,408...57,111,362
Ensembl chr12:57,095,408...57,132,139
JBrowse link
G STC2 stanniocalcin 2 ISO mRNA:increased expression:mammary gland RGD PMID:18959458 RGD:2313895 NCBI chr 5:173,314,723...173,328,414
Ensembl chr 5:173,314,723...173,328,447
JBrowse link
G STMN1 stathmin 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 1:25,884,179...25,906,880
Ensembl chr 1:25,884,181...25,906,991
JBrowse link
G TDG thymine DNA glycosylase ISO mRNA:increased expression:mammary gland tumor (mouse) RGD PMID:9794235 RGD:2317355 NCBI chr12:103,965,872...103,988,874
Ensembl chr12:103,965,822...103,988,874
JBrowse link
G TERC telomerase RNA component ISO RNA:increased expression:mammary gland RGD PMID:9857231 RGD:2291975 NCBI chr 3:169,764,610...169,765,060
Ensembl chr 3:169,764,610...169,765,047
Ensembl chr 3:169,764,610...169,765,047
JBrowse link
G TF transferrin EXP CTD Direct Evidence: marker/mechanism CTD PMID:9879772 PMID:16316942 NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641
JBrowse link
G TFF1 trefoil factor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21283680 NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535
JBrowse link
G TGFA transforming growth factor alpha EXP CTD Direct Evidence: marker/mechanism CTD PMID:8603490 NCBI chr 2:70,447,284...70,553,826
Ensembl chr 2:70,447,284...70,554,193
JBrowse link
G TGFB1 transforming growth factor beta 1 ISO RGD PMID:8466857 RGD:7394797 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
JBrowse link
G TGFBR1 transforming growth factor beta receptor 1 IMP RGD PMID:12808151 RGD:737735 NCBI chr 9:99,104,038...99,154,192
Ensembl chr 9:99,104,038...99,154,192
JBrowse link
G TGFBR2 transforming growth factor beta receptor 2 IMP RGD PMID:12808151 RGD:737735 NCBI chr 3:30,606,356...30,694,142
Ensembl chr 3:30,606,601...30,694,142
JBrowse link
G THBS1 thrombospondin 1 ISO mRNA:increased expression:mammary gland RGD PMID:15459484 RGD:1626167 NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
JBrowse link
G THRSP thyroid hormone responsive EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr11:78,063,861...78,068,351
Ensembl chr11:78,063,861...78,068,351
JBrowse link
G TKT transketolase EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 3:53,224,712...53,256,022
Ensembl chr 3:53,224,712...53,256,052
JBrowse link
G TLE4 TLE family member 4, transcriptional corepressor EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 9:79,571,965...79,726,882
Ensembl chr 9:79,571,773...79,726,882
JBrowse link
G TNF tumor necrosis factor ISO RGD PMID:19755514 RGD:7401185 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TNFRSF10A TNF receptor superfamily member 10a ISO RGD PMID:17671220 RGD:2290495 NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102
JBrowse link
G TNFRSF10B TNF receptor superfamily member 10b ISO RGD PMID:17671220 RGD:2290495 NCBI chr 8:23,020,133...23,069,031
Ensembl chr 8:23,020,133...23,069,031
JBrowse link
G TNFSF10 TNF superfamily member 10 EXP CTD Direct Evidence: therapeutic CTD PMID:21252285 NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
JBrowse link
G TP53 tumor protein p53 disease_progression ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:24809783 PMID:17470299 PMID:18092324 RGD:2290577, RGD:2290539 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
G TPM3 tropomyosin 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 PMID:16316942 NCBI chr 1:154,155,308...154,192,100
Ensembl chr 1:154,155,304...154,194,648
JBrowse link
G TRPS1 transcriptional repressor GATA binding 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 8:115,408,496...115,668,975
Ensembl chr 8:115,408,496...115,809,673
JBrowse link
G TSC22D1 TSC22 domain family member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr13:44,432,143...44,577,344
Ensembl chr13:44,432,143...44,577,147
JBrowse link
G TUBB2B tubulin beta 2B class IIb EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 6:3,224,277...3,227,653
Ensembl chr 6:3,223,324...3,231,730
JBrowse link
G TXNIP thioredoxin interacting protein severity ISO mRNA:decreased expression:mammary gland RGD PMID:15170812 RGD:1642758 NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
JBrowse link
G TYMS thymidylate synthetase ISO RGD PMID:9635926 RGD:2315839 NCBI chr18:657,653...673,578
Ensembl chr18:657,653...673,578
JBrowse link
G UBE2I ubiquitin conjugating enzyme E2 I IDA
EXP
MCF-7 human breast cancer cell tumors grown in nude mice
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16316942 PMID:15735760 RGD:2301345 NCBI chr16:1,309,152...1,327,017
Ensembl chr16:1,308,880...1,327,018
JBrowse link
G UCP2 uncoupling protein 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,672...73,982,843
JBrowse link
G VAMP8 vesicle associated membrane protein 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16316942 NCBI chr 2:85,577,586...85,582,031
Ensembl chr 2:85,561,562...85,582,031
JBrowse link
G VDR vitamin D receptor ISO RGD PMID:15333467 RGD:8158073 NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
JBrowse link
G VEGFA vascular endothelial growth factor A treatment IDA human protein in a mouse model RGD PMID:21890879 RGD:6771361 NCBI chr 6:43,770,209...43,786,487
Ensembl chr 6:43,770,184...43,786,487
JBrowse link
G WNT1 Wnt family member 1 ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:8065359 PMID:9419423 RGD:2298863, RGD:2298848 NCBI chr12:48,978,322...48,982,620
Ensembl chr12:48,978,322...48,982,620
JBrowse link
G WNT2 Wnt family member 2 IDA in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 PMID:8065359 RGD:2298848, RGD:2298863 NCBI chr 7:117,275,451...117,323,058
Ensembl chr 7:117,275,451...117,323,152
JBrowse link
G WNT3 Wnt family member 3 IDA in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 RGD:2298848 NCBI chr17:46,830,790...46,833,102
Ensembl chr17:46,762,506...46,833,154
JBrowse link
G WNT3 Wnt family member 3 ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 RGD:2298848 NCBI chr17:46,762,506...46,818,692
Ensembl chr17:46,762,506...46,833,154
JBrowse link
G WNT3A Wnt family member 3A ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 PMID:8065359 RGD:2298848, RGD:2298863 NCBI chr 1:228,006,998...228,061,271
Ensembl chr 1:228,006,998...228,061,271
JBrowse link
G WNT5B Wnt family member 5B no_association ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 PMID:8065359 RGD:2298848, RGD:2298863 NCBI chr12:1,617,056...1,647,212
Ensembl chr12:1,529,891...1,647,212
JBrowse link
G WNT6 Wnt family member 6 no_association ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 PMID:8065359 RGD:2298848, RGD:2298863 NCBI chr 2:218,859,805...218,874,233
Ensembl chr 2:218,859,805...218,874,233
JBrowse link
G WNT7A Wnt family member 7A ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:9419423 PMID:8065359 RGD:2298848, RGD:2298863 NCBI chr 3:13,816,258...13,880,071
Ensembl chr 3:13,816,258...13,880,071
JBrowse link
G WNT7B Wnt family member 7B no_association ISO in vitro transformation of transfected C57MG mammary epithelial cell line RGD PMID:8065359 PMID:9419423 RGD:2298863, RGD:2298848 NCBI chr22:45,920,366...45,977,162
Ensembl chr22:45,920,366...45,977,162
JBrowse link
G XDH xanthine dehydrogenase EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742
JBrowse link
G XIAP X-linked inhibitor of apoptosis EXP CTD Direct Evidence: therapeutic CTD PMID:12766084 NCBI chr  X:123,859,708...123,913,972
Ensembl chr  X:123,859,712...123,913,972
JBrowse link
G XRCC3 X-ray repair cross complementing 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21283680 NCBI chr14:103,697,617...103,715,451
Ensembl chr14:103,697,609...103,715,504
JBrowse link
G YWHAZ tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta EXP CTD Direct Evidence: marker/mechanism CTD PMID:12376462 NCBI chr 8:100,916,523...100,953,382
Ensembl chr 8:100,916,523...100,953,388
JBrowse link
Sarcoma, Yoshida term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DPYD dihydropyrimidine dehydrogenase treatment ISO RGD PMID:8138551 RGD:11251753 NCBI chr 1:97,077,743...97,921,059
Ensembl chr 1:97,077,743...97,995,000
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  disease 22089
    disease of cellular proliferation 8443
      Experimental Neoplasms 517
        Carcinoma 256, Walker 0
        Carcinoma, Brown-Pearce 0
        Carcinoma, Krebs 2 0
        Carcinoma, Lewis Lung 11
        Ehrlich tumor carcinoma 3
        Experimental Leukemia + 10
        Experimental Liver Neoplasms 164
        Experimental Melanoma 23
        Experimental Sarcoma + 9
        Mammary Neoplasms, Experimental 290
Path 2
Term Annotations click to browse term
  disease 22089
    Animal Diseases 1363
      Animal Disease Models 1316
        Experimental Neoplasms 517
          Carcinoma 256, Walker 0
          Carcinoma, Brown-Pearce 0
          Carcinoma, Krebs 2 0
          Carcinoma, Lewis Lung 11
          Ehrlich tumor carcinoma 3
          Experimental Leukemia + 10
          Experimental Liver Neoplasms 164
          Experimental Melanoma 23
          Experimental Sarcoma + 9
          Mammary Neoplasms, Experimental 290
paths to the root